25
Fri

27

Nov 2020
PhD Defense

Investigating mechanisms of RNA degradation during the oocyte-to-embryo transition

  13:00 - 14:00
  Zoom

Speaker: Luis Enrique Cabrera Quio
Institute: IMP - Pauli Lab

Fri

27

Nov 2020
Impromptu Seminar

Precision Medicine: A Translational Research Perspective

  09:00 - 10:00
  Zoom

Speaker: Pilar Garin-Chesa
Institute: IMP
Host: Anna Obenauf

Mon

30

Nov 2020
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  Zoom

Speaker: MILJKOVIC Frane (Köhler), STOCKINGER Alexander (Raible), SUGIURA Takuji (Tanaka)
Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Tue

01

Dec 2020
Vienna Biocenter Climate Lecture Series

Greenland ice cores, greenhouse gases, climate change and you/Yes, wen can get to zero Co2 emissions

  16:00 - 17:00
  Zoom

Speaker: Bruce Vaughn/Antony Patt
Institute: University of Colorado/ETH-IPCC author
Host: Climate@Max Perutz Labs

Wed

02

Dec 2020
Impromptu Seminar

Investigating the cytoplasmic pool of centriolar proteins

  14:00 - 15:00
  Zoom

Speaker: Thomas Steinacker
Institute: University of Oxford
Host: Daniel Gerlich

Thu

03

Dec 2020
Seminar Series on Modern Concepts in Structural Biology

Imagining the life and death of mRNAs in single cells

  14:00 - 15:00
  Zoom

Speaker: Jeffrey Chao
Institute: FMI
Host: Sebastian Falk

Thu

03

Dec 2020
VBC Regular Seminar via Zoom

"Exchange timer": a new strategy for proofing nucleosome exchange in-vivo

  11:00 - 12:00
  Zoom

Speaker: Naama Barkai
Institute: Weizmann Institute of Science
Host: Luisa Cochella

Mon

07

Dec 2020
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: FAHRENBERGER Martin (Von Haeseler), BRAGULAT TEIXIDOR Helena (Otuska), DA CUNHA E SILVA MARTINS COSTA Catarina (Knoblich),
Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Mon

14

Dec 2020
VDS Lecture

Studying early mammalian development using single-cell genomics

  17:00 - 18:00
  IMBA/GMI Lecture Hall

Speaker: John Marioni
Institute: EMBL-EBI
Host: Arndt von Haeseler

Mon

14

Dec 2020
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: DUXBURY Zane (Becker), RAUSCHMEIER Rene (Busslinger), CERRON ALVAN Luis Miguel (Leeb)
Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Thu

17

Dec 2020
Seminar Series on Modern Concepts in Structural Biology

Title to be announced

  14:00 - 15:00
  Zoom

Speaker: Andreas Schwaighofer
Institute: TU Wien
Host: Arthur Sedivy

Thu

17

Dec 2020
VBC Regular Seminar via Zoom

Epigenetics and Synthetic Lethality

  11:00 - 12:00
  Zoom

Speaker: Christopher Vakoc
Institute: Cold Spring Harbor Laboratory
Host: Johannes Zuber

Mon

21

Dec 2020
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: ANISIMOVA Aleksandra (Karagöz), LIN Tzi-Yang (Tanaka), ANDREATTA Gabriele (Raible)
Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Mon

11

Jan 2021
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: KHANDEKAR Ameya (Martinez), LOUBIERE Vincent (Stark), NGUYEN Vu (Mittelsten Scheid)
Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Mon

18

Jan 2021
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: PINTER Theresa (Busslinger), MANDLBAUER Ariane (Cochella), CLARKE Amy (Zagrovic)
Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Thu

21

Jan 2021
VBC Regular Seminar

Title to be announced

  11:00 - 12:00
  IMBA/GMI Lecture Hall

Speaker: Clifford Brangwynne
Institute: Princeton University
Host: Daniel Gelrich

Mon

25

Jan 2021
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: SANITLLAN Emilio (Cochella), HOLCIK Laurenz (Von Haeseler), KAWAGUCHI Akane (Tanaka)
Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Thu

28

Jan 2021
VBC Regular Seminar

Histone variants and their chaperones a network in action

  11:00 - 12:00
  Zoom

Speaker: Genevieve Almouzni
Institute: Institute Curie
Host: Fred Berger

Mon

01

Feb 2021
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: HAENDELER Simon (Von Haeseler), KRAMMER Teresa (Tanaka), DENEKE Victoria (Pauli)
Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Thu

04

Feb 2021
VBC Regular Seminar

Title to be announced

  11:00 - 12:00
  IMBA/GMI Lecture Hall

Speaker: Arjun Raj
Institute: University of Pennsylvania
Host: Alex Stark

Mon

08

Feb 2021
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: LEITNER Marie-Christin (Mendjan), YU Changwei (Brennecke), ALMEIDA Bernardo (Stark)
Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Mon

15

Feb 2021
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: LORENZO ORTS Laura (Pauli), HORN Sabrina (Peters), SEONG Jinwoo (Rivron)
Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Mon

22

Feb 2021
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: SAAD RODRIGUES Carolina (Schloegelhofer), OTSUKI Leo (Tanaka), SCHMIDT Clara (Mendjan)
Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Thu

25

Feb 2021
VBC Regular Seminar

Title to be announced

  11:00 - 12:00
  IMBA/GMI Lecture Hall

Speaker: Linda Partridge
Institute: MPI for Biology of Aeging
Host: Noelia Urban

Mon

01

Mar 2021
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: LÖFKE Christian (Dagdas), SAVOVA Adriana(Martens), TAKACS Zsuzsanna (Gerlich)
Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Tue

02

Mar 2021
VBC Regular Seminar

Title to be announced

  11:00 - 12:00
  IMBA/GMI Lecture Hall

Speaker: Oliver Hobert
Institute: Columbia University
Host: Luisa Cochella, Elly Tanaka

Tue

02

Mar 2021
Wed

03

Mar 2021
Symposium

SY-Stem

  09:00 - 10:00
  IMP Lecture Hall
Mon

08

Mar 2021
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: BATTY Paul Daniel (Gerlich), JACOBS Jelle (Stark), BAUMANN Verena (Martens)
Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Thu

11

Mar 2021
VBC Regular Seminar

Title to be announced

  11:00 - 12:00
  IMBA/GMI Lecture Hall

Speaker: Silvia Cappello
Institute: MPI of Psychiatry Munich
Host: Sofia Grade

Mon

15

Mar 2021
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: RITSCHKA Birgit (Tanaka), LEIENDECKER Lukas (Obenauf), PISUPATI Rahul Bharadwaj (Nordborg)
Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Mon

22

Mar 2021
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: VOGEL Antonia (Clausen), INCARBONE Marco (Mittelsten Scheid), TELONI Federico (Gerlich)
Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Thu

25

Mar 2021
VBC Regular Seminar

Title to be announced

  11:00 - 12:00
  IMBA/GMI Lecture Hall

Speaker: Thijn Brummelkamp
Institute: Netherlands Cancer Institute
Host: Johannes Zuber

Mon

29

Mar 2021
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: AYALA MUNOZ Farja Isabel (Plaschka), HOLZMANN Viktoria (Rivron), STALTNER Moritz (Ameres)
Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Thu

01

Apr 2021
Cancelled

Title to be announced

  11:00 - 12:00
  IMBA/GMI Lecture Hall

Speaker: Doug Higgs
Institute: MRC Weatherall Institute of Medicine
Host: Rushad Pavri

Thu

08

Apr 2021
VBC Regular Seminar

Title to be announced

  11:00 - 12:00
  IMBA/GMI Lecture Hall

Speaker: Dana Peer
Institute: Memorial Sloan Kettering Cancer Center
Host: Anna Obenauf

Mon

12

Apr 2021
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: BASSAT Elad (Tanaka), RUANGROENGKULRITH Siwat (Tachibana), DOMBEY Rodolphe (Mari-Ordonez)
Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Thu

15

Apr 2021
VBC Regular Seminar

Title to be announced

  11:00 - 12:00
  IMBA/GMI Lecture Hall

Speaker: Jennifer Lippincott-Schwartz
Institute: Janelia Farm
Host: Kristina Djinovic Carugo

Mon

19

Apr 2021
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: FEDL Anna (Busslinger), TERIYAPIROM Isaree (Koo), LI Chong (Knoblich)
Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Wed

21

Apr 2021
Symposium

Microsymposium on Small RNA Biology

  09:00 - 10:00
  IMP Lecture Hall
Mon

26

Apr 2021
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: LIU Haijun (Nordborg), GEHRE Maja (Brennecke), NEMCKO Filip (Stark)
Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Wed

28

Apr 2021
Max Birnstiel Lecture

Title to be announced

  11:00 - 12:00
  IMP Lecture Hall

Speaker: Joan Massague
Institute: Memorial Sloan Kettering Cancer Center
Host: Anna Obenauf

Thu

29

Apr 2021
VBC Regular Seminar

Title to be announced

  11:00 - 12:00
  IMBA/GMI Lecture Hall

Speaker: Martin Beck
Institute: MPI of Biophysics
Host: Clemens Plaschka, Shotaro Otsuka

Mon

03

May 2021
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: NAVALAYEU Tsimafei (Ameres), ZMAJKOVIC Jakub (Zuber), JONSSON Gustav (Penninger)
Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Wed

05

May 2021
Max Birnstiel Lecture

Title to be announced

  11:00 - 12:00
  IMP Lecture Hall

Speaker: Richard Flavell
Institute: Yale University School of Medicine
Host: Meinrad Busslinger

Thu

06

May 2021
VBC Regular Seminar

Title to be announced

  11:00 - 12:00
  IMBA/GMI Lecture Hall

Speaker: Rahul Satija
Institute: New York Genome Center
Host: Andi Pauli

Mon

10

May 2021
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: HINTERNDORFER Matthias (Zuber), KORESHOVA Alevtina (Burga), REUMANN Daniel (Knoblich)
Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Mon

17

May 2021
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: NOGALES MORAL Adrian (Köhler), NAJM Ramsey K. (Knoblich)
Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Wed

26

May 2021
Max Birnstiel Lecture

Title to be announced

  11:00 - 12:00
  IMP Lecture Hall

Speaker: Ulrich Hartl
Institute: Max Planck Institute of Biochemistry
Host: Tim Clausen

Thu

27

May 2021
VBC Regular Seminar

Title to be announced

  11:00 - 12:00
  IMBA/GMI Lecture Hall

Speaker: David Gilbert
Institute: Florida State University
Host: Rushad Pavri

Mon

31

May 2021
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: CHUGUNOVA Anastasia (Pauli), REITER Franziska (Stark), SGROMO Annamaria (Ameres)
Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Mon

07

Jun 2021
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: PHILLIPS Alexander William (Keays), WIDEN Sonya Angeline (Burga), VOICHEK Yoav (Nordborg)
Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Thu

10

Jun 2021
VBC Regular Seminar

Title to be announced

  11:00 - 12:00
  IMBA/GMI Lecture Hall

Speaker: Hitoshi Kurumizaka
Institute: University of Tokyo
Host: Kikue Tachibana

Fri

11

Jun 2021
Impromptu Seminar

Title to be announced

  11:00 - 12:00
  IMP Lecture Hall

Speaker: Jan Boettcher
Institute: TU Munich
Host: Anna Obenauf

Mon

14

Jun 2021
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: RODIRUGEZ TERRONES Diego (Tanaka), KORDIC Darja (Clausen), PERSCHY Lorenz (Haselbach)
Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Thu

17

Jun 2021
VBC Regular Seminar

Title to be announced

  11:00 - 12:00
  IMBA/GMI Lecture Hall

Speaker: Gioacchino Natoli
Institute: Humanitas University
Host: Meinrad Busslinger

Mon

21

Jun 2021
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: GARCIA LEON Marta (Dagdas), KLAUS Loni (Stark), JAVALI Alok (Rivron)
Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Mon

28

Jun 2021
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: VOICHEK Maya Shinan (Brennecke), PETRZILEK Jan (Ameres), KALIS Robert (Zuber)
Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Thu

08

Jul 2021
VBC Regular Seminar

Title to be announced

  11:00 - 12:00
  IMBA/GMI Lecture Hall

Speaker: Fanni Gergely
Institute: Cancer Research UK, Cambridge Institute
Host: Alex Dammermann

Mon

12

Jul 2021
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: ELEWAUT Anais (Obenauf), ANDRIONE Mara (Zimmer), DAO Pauline (Tessmar)
Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Thu

15

Jul 2021
VBC Regular Seminar

Title to be announced

  11:00 - 12:00
  IMBA/GMI Lecture Hall

Speaker: Valter Longo
Institute: USC Leonard David School of Gerontology
Host: Noelia Urban

Mon

19

Jul 2021
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: SALAZAR THULA Oriana Ylida (Zimmer), DUKIC Dejan (Nordborg), HANDLER Dominik (Brennecke)
Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Thu

22

Jul 2021
VBC Regular Seminar

Title to be announced

  11:00 - 12:00
  IMBA/GMI Lecture Hall

Speaker: Stefano Di Talia
Institute: Duke University Medical Center
Host: Andi Pauli

Mon

26

Jul 2021
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: LEE Du-Hwa (Belkhadir), PACHINGER Claudia (Dammermann lab), BAUMGARTNER Lisa (Brennecke)
Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Mon

02

Aug 2021
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: TRASSER Marieke (Mari-Ordonez), JUNKER Sabryna (Clausen), GERT Krista (Pauli)
Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Mon

09

Aug 2021

Monday Seminar (Internal)

  12:30 - 13:30

Speaker: HOI David (Clausen), HENDY Oliver (Stark)

Mon

16

Aug 2021
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: DE ALMEIDA Melanie (Zuber), BRADAMANTE Gabriele (Mittelsten Scheid), VEEDIN RAJAN Vinoth Babu (Urban)
Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Mon

23

Aug 2021
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: HARVEY Zachary (Berger), PACHECO FIALLOS Francis Belen (Plaschka), WU Szu-Hsien (Koo)
Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Mon

30

Aug 2021
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: SESTINI Giovanni (Rivron), MORREALE Francesca (Clausen), PASAJILIC Djurdja (Martinez)
Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Thu

02

Sep 2021
VBC Regular Seminar

Title to be announced

  11:00 - 12:00
  IMBA/GMI Lecture Hall

Speaker: Taekjip Ha
Institute: Johns Hopkins University
Host: Clemens Plaschka

Mon

06

Sep 2021
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: CORSI Flavia (Golobordko), BRUNNER Hanna (Haselbach), CRONIN Shona (Obenauf)
Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Thu

09

Sep 2021
VBC Regular Seminar

Title to be announced

  11:00 - 12:00
  IMBA/GMI Lecture Hall

Speaker: Holger Puchta
Institute: Karlsruhe Institute of Technology (KIT)
Host: Ortrun Mittelsten Scheid

Mon

13

Sep 2021
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: LEHMANN Christian (Knoblich), MURPHY Paul (Clausen), HISANAGA Tetsuya (Berger)
Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Thu

16

Sep 2021
VBC Regular Seminar

Title to be announced

  11:00 - 12:00
  IMBA/GMI Lecture Hall

Speaker: Didier Stainier
Institute: MPI for Heart and Lung Research
Host: Elly Tanaka

Mon

20

Sep 2021
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: SPICER Maximilian (Gerlich), GRÜNBACHER Sarah (Busslinger), VERTESY Abel (Knoblich)
Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Thu

23

Sep 2021
VBC Regular Seminar

Title to be announced

  11:00 - 12:00
  IMBA/GMI Lecture Hall

Speaker: Richard Youle
Institute: NIH
Host: Sascha Martens

Mon

27

Sep 2021
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: BUENDIA Daniel (Mari-Ordonez), POLIKARPOVA Anastasia (Tanaka), LEESCH Katrin Friederike (Pauli)
Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Thu

30

Sep 2021
VBC Regular Seminar

Title to be announced

  11:00 - 12:00
  IMBA/GMI Lecture Hall

Speaker: Andrew Dillin
Institute: University of California, Berkeley
Host: Yasin Dagdas

Mon

04

Oct 2021
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: PANAROTTO-PERICLES Melanie (Peters), LEE Ho-Soek (Belkhadir), CHAKRABORTY Oisorjo (Grade)
Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Mon

11

Oct 2021
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: LEE Ji-Hyun (Koo), PETROVIC Mina (Gerlich), BELACIC Katarina (Haselbach)
Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Thu

14

Oct 2021
VBC Regular Seminar

Title to be announced

  11:00 - 12:00
  IMBA/GMI Lecture Hall

Speaker: Nevan Krogan
Institute: UCSF - Gladstone Institute
Host: Manuela Baccarini

Mon

18

Oct 2021
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: SHIRZADIAN YAZD Mehrta (Balzarotti), KOLESNIKOVA Sofia (Gerlich), BAUCELLS Julia Garcia (Dammermann)
Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Wed

20

Oct 2021
Max Birnstiel Lecture

Title to be announced

  11:00 - 12:00
  IMP Lecture Hall

Speaker: John Diffley
Institute: The Francis Crick Institute
Host: Rushad Pavri, Jan-Michael Peters

Thu

21

Oct 2021
VBC Regular Seminar

Title to be announced

  11:00 - 12:00
  IMBA/GMI Lecture Hall

Speaker: Azim Surani
Institute: Gurdon Institute, University of Cambridge
Host: Andi Pauli

Mon

25

Oct 2021
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: HOLSTEIN Felix (Obenauf), KHALDIEH Nina (Ameres), HOHMANN Ulrich (Brennecke/Plaschka)
Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Thu

28

Oct 2021
VBC Regular Seminar

Title to be announced

  11:00 - 12:00
  IMBA/GMI Lecture Hall

Speaker: Michael Lichten
Institute: NIH
Host: Peter Schlögelhofer

Mon

08

Nov 2021
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: NAVA GARCIA Marintia Mayola (Köhler), TARDIVO Pietro (Tanaka), GEISMANN Maximilian (Balzarotti)
Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Thu

11

Nov 2021
VBC Regular Seminar

Title to be announced

  11:00 - 12:00
  IMBA/GMI Lecture Hall

Speaker: Julia Mahamid
Institute: EMBL
Host: Shamba Saha

Mon

15

Nov 2021
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: SCHMUECKER Anna (Berger), VOGT Vivien (Zuber), HEIDARI KHOEI Heidar (Rivron)
Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Thu

18

Nov 2021
VBC Regular Seminar

Title to be announced

  11:00 - 12:00
  IMBA/GMI Lecture Hall

Speaker: Alejandro Sanchez Alvarado
Institute: Stowers Inst. for Medical Research
Host: Elly Tanaka

Wed

24

Nov 2021
Max Birnstiel Lecture

Title to be announced

  11:00 - 12:00
  IMP Lecture Hall

Speaker: Patrick Cramer
Institute: MPI for Biophysical Chemistry
Host: Alexander Stark, Clemens Plaschka

Thu

25

Nov 2021
VBC Regular Seminar

Title to be announced

  11:00 - 12:00
  IMBA/GMI Lecture Hall

Speaker: Steve Jackson
Institute: Gurdon Research Institute
Host: Rushad Pavri

Thu

02

Dec 2021
VBC Regular Seminar

Title to be announced

  11:00 - 12:00
  IMBA/GMI Lecture Hall

Speaker: Adele Marston
Institute: Wellcome Centre Cell Biology, University of Edinburgh
Host: Daniel Gerlich, Joao Matos

Mon

06

Dec 2021
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: ROSS James (Brennecke), ISBANER Sebastian (Balzarotti), STREUBEL Susanna (Dolan)
Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Thu

09

Dec 2021
VBC Regular Seminar

Title to be announced

  11:00 - 12:00
  IMBA/GMI Lecture Hall

Speaker: Kai Johnsson
Institute: MPI for Medical Research
Host: Daniel Gerlich

Mon

13

Dec 2021
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: HAJDUSITS Bence (Clausen), ZHAO Jierui (Dagdas), ISHIHARA Keisuke (Tanaka)
Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Thu

16

Dec 2021
VBC Regular Seminar

Title to be announced

  11:00 - 12:00
  IMBA/GMI Lecture Hall

Speaker: Xin Chen
Institute: Johns Hopkins University
Host: Fred Berger

Mon

20

Dec 2021
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: VALLEBUENO Miguel (Swarts), SAJTOS Bettina (Zuber), NAGUMO WONG Sakurako (Knoblich)
Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Mon

10

Jan 2022
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: LUST Katharina (Tanaka), CLAVEL Marion (Dagdas), TIKANOVA Polina (Burga)
Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Mon

17

Jan 2022
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: CTORTECKA Claudia (Mendjan), MULVEY Hugh (Dolan), LORBEER Franziska (Stark)
Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Mon

24

Jan 2022
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: SCHELLHAAS Ulla (Plaschka), MEREITER Stefan (Penninger), RADHAKRISHNA PILLAI Balashankar (Saha)
Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Mon

31

Jan 2022
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: COLOZZA Gabriele (Koo), BLAHA Andreas (Pauli), PÜHRINGER Florian (Burga)
Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Mon

07

Feb 2022
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: JUNG Pauline (Obenauf), LICHT-MAYER Simon (Penninger), CAYGILL Samuel (Dolan)
Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

Mon

14

Feb 2022
Monday Seminar

Monday Seminar (Internal)

  12:30 - 13:30
  IMP Lecture Hall

Speaker: FALCON CHAVEZ Francisco Javier (Tanaka), KOK Jian Yi (Berger), VORLÄNDER Matthias (Plaschka)
Institute: Open only to IMP/IMBA/GMI/Max Perutz Labs

  • Name
    Phone
    Mail
    Function
    Group
    Room
  • A
  • Dana Abdeen
    +43-1-4277-56261
    PhD Student
    Jantsch V
    5.522
    Main Building
  • Omer Rashid Abdi
    +43-1-4277-61643
    Apprentice
    Köhler A
    3.524
    Main Building
  • Marlene Adlhart
    +43-1-4277-24001
    Zagrovic
    1.114
    VBC 5
  • Christiane Agreiter
    +43-1-4277-56221
    Technician
    Loidl
    5.515
    Main Building
  • Mariam Al-Rawi
    +43-1-4277-74040
    Technician Vienna COVID-19 Detection Initiative
    Köhler A
    4622
    VBC 5
  • Mustafa Alaabo
    +43-1-4277-52808
    Campbell
    5.512/5.513
    Main Building
  • Tanino Albanese
    +43-1-4277-54632
    Technician
    Moll
    4.129
    Main Building
  • Manuel Alonso Y Adell
    +43-1-4277-52808
    PostDoc
    Campbell
    5.512/5.513
    Main Building
  • Thomas Altmutter
    +43-1-4277-24003
    IT Support
    3.117
    Main Building
  • Jolanta Ambroz-Kumorowski
    +43-1-4277-24061
    Facility Technician
    8.318
    Main Building
  • Gustav Ammerer
    +43-1-4277-52816
    Group Leader
    Ammerer
    5.113
    Main Building
  • Biljana Andjelkovic
    +43-1-4277-54630
    Diploma/Master Student
    Baccarini
    4.529
    Main Building
  • Gabriele Andreatta
    +43-1-4277-74636
    PostDoc
    Raible
    4.501
    Main Building
  • Yasmine Angerer
    +43-1-4277-24072
    Facility Staff
    1.117
    Main Building
  • Aleksandra Anisimova
    +43-1-4277-61653
    PhD Student
    Karagöz
    3.507/ 3.508
    Main Building
  • Dorothea Anrather
    +43-1-4277-52846
    Senior PostDoc
    5.10
    IMP/IMBA
  • Lisa Appel
    +43-1-4277-52807
    PhD Student
    Slade
    5.508
    Main Building
  • Silvia Arce Solano
    +43-1-4277-52225
    PhD Student
    Djinovic
    0612
    VBC 5
  • Alexis Arizpe
    +43-1-79044-9942
    PhD Student
    Swarts
    1104
    VBC 5
  • Hossein Arzani
    +43-1-4277-61812
    PhD Student
    Kuchler
    2.107
    Main Building
  • Igor Asanovic
    +43-1-4277-61815
    PhD Student
    Martinez
    2.512
    Main Building
  • Gerlinde Aschauer
    +43-1-4277-52851
    Program manager
    5.119
    Main Building
  • Grace Abiola Atteh
    +43-1-4277-52236
    Diploma/Master Student
    Djinovic
    0326
    VBC 5
  • Markus Auler
    +43-1-4277-54629
    PhD Student
    Baccarini
    4.529
    Main Building
  • Zahra Ayatollahi
    +43-1-4277-61609
    PostDoc
    Barta
    3.518
    Main Building
  • B
  • Manuela Baccarini
    +43-1-4277-54607
    Group Leader
    Baccarini
    4.628
    Main Building
  • Andreas Bachmair
    +43-1-4277-74811
    Group Leader
    Bachmair
    5.110
    Main Building
  • Matthias Bärnthaler
    +43-1-4277-24041
    Head of IT
    4.420
    Main Building
  • Andrea Barta
    +43-1-4277-61640
    Lecturer
    Barta
    3.520
    Main Building
  • Antoine Baudrimont
    +43-1-4277-56261
    PostDoc
    Jantsch V
    5.522
    Main Building
  • Verena Baumann
    +43-1-4277-52838
    PhD Student
    Martens
    5.401
    Main Building
  • Andreas Beier
    +43-1-4277-52227
    PhD Student
    Konrat
    0614
    VBC 5
  • Andrej Belokurov
    +43-1-4277-24080
    Facility Technician
    Tessmar
    0.413
    Main Building
  • Johannes Benedum
    +43-1-4277-52807
    Diploma/Master Student
    Slade
    5.508
    Main Building
  • Maximilian Benesch
    +43-1-4277-56221
    Klein
    5.528/5.530
    Main Building
  • Christian Bernhart
    +43-1-4277-52812
    IT Support
    5.617
    Main Building
  • Daniel Bernklau
    +43-1-4277-52828
    PhD Student
    Martens
    5.502
    Main Building
  • Patrick Berthold
    +43-1-4277-24072
    Facility Staff
    1.117
    Main Building
  • Annika Bestehorn
    +43-1-4277-54626
    PhD Student
    Kovarik
    4.514
    Main Building
  • Angela Bienert
    +43-1-4277-61811
    Administration
    Kuchler
    2.107
    Main Building
  • Ivana Bilusic
    +43-1-4277-52804
    PhD Student
    Schroeder
    5.502
    Main Building
  • Wolfgang Binder
    +43-1-4277-24060
    Technician
    3.501
    Main Building
  • Michael Bindl
    +43-1-4277-61645
    Diploma/Master Student
    Leeb
    3.123/3.125
    Main Building
  • Head of Biooptics Facility
    +43-1-4277-61672
    PostDoc
    1.618
    VBC 5
  • Nora Bischoff
    +43-1-4277-54627
    Technician
    Kovarik
    4.514
    Main Building
  • Dieter Blaas
    +43-1-4277-61630
    Group Leader
    Blaas
    3.026
    Main Building
  • Udo Bläsi
    +43-1-4277-54609
    Group Leader
    Bläsi
    4.121
    Main Building
  • Laura Boccuni
    +43-1-4277-54628
    PhD Student
    Decker
    4.522/4.524
    Main Building
  • Jörg Böckelmann
    +43-1-4277-52206
    Administration
    Djinovic
    1.604
    VBC 5
  • Martina Borroni
    +43-1-4277-54627
    PhD Student
    Kovarik
    4.514
    Main Building
  • Margaryta Borysova
    +43-1-4277-74639
    Facility Technician
    0.310
    Main Building
  • Veronika Boskova
    +43-1-4277-74330
    PostDoc
    v. Haeseler
    1.812.3
    VBC 5
  • Michaela Bradlerova
    +43-1-4277-54628
    Diploma/Master Student
    Decker
    4.522/4.524
    Main Building
  • Helena Bragulat Teixidor
    +43-1-4277-61668
    PhD Student
    Otsuka
    3.505
    Main Building
  • Ana Brandic
    +43-1-4277-52866
    Fuchs
    5.506
    Main Building
  • Daniel Braun
    +43-1-4277-52272
    PostDoc
    Zagrovic
    1.114
    VBC 5
  • Barbara Brumec
    +43-1-4277-61661
    Technician
    3.518
    Main Building
  • Sven Brüschweiler
    +43-1-4277-52227
    Senior PostDoc
    Konrat
    0614
    VBC 5
  • Michael Bryant
    +43-1-4277-54607
    Diploma/Master Student
    Baccarini
    4.525/4.527
    Main Building
  • Valentina Budroni
    +43-1-4277-54164
    PhD Student
    Versteeg
    4.108
    Main Building
  • Christa Buecker
    +43-1-4277-74646
    Group Leader
    Bücker
    3.626
    Main Building
  • Pisanu Buphamalai
    +43-1-4277-74391
    PhD Student
    Menche
    1803
    VBC 5
  • Sebastian Burgstaller-Muehlbacher
    +43-1-4277-74324
    PostDoc
    v. Haeseler
    1.812.4
    VBC 5
  • Virginia Busetto
    +43-1-4277-74320
    PostDoc
    Falk
    1.624
    VBC 5
  • C
  • Michael Caldera
    +43-1-4277-74391
    PhD Student
    Menche
    1104
    VBC 5
  • Christopher Campbell
    +43-1-4277-52808
    Group Leader
    Campbell
    5.610
    Main Building
  • Oliviero Carugo
    +43-1-4277-52208
    Djinovic
    1.120
    VBC 5
  • Irene Ceccolini
    +43-1-4277-52229
    PhD Student
    Konrat
    0614
    VBC 5
  • Luis Miguel Cerron Alvan
    +43-1-4277-74645
    PhD Student
    Leeb
    3.123/3.125
    Main Building
  • Weiqiang Chen
    +43-1-4277-52846
    Senior PostDoc
    5.10
    IMP/IMBA
  • Doris Chen
    +43-1-4277-74328
    PostDoc
    Klein
    1.812.3
    VBC 5
  • Olga Chernomor
    +43-1-4277-74325
    PostDoc
    v. Haeseler
    1.812.4
    VBC 5
  • Martin Chiettini
    +43-1-4277-74390
    Technician
    Menche
    1803
    VBC 5
  • Marius Constantin Chirita Mihaila
    +43-1-4277-52213
    PhD Student
    Juffmann
    1.614
    VBC 5
  • Woong Jae Choi
    +43-1-4277-52241
    Leonard
    1.222
    VBC 5
  • Anastasia Cianciulli Sesso
    +43-1-4277-54631
    PhD Student
    Bläsi
    4.122/4.124
    Main Building
  • Christiane Cladrowa
    +43-1-4277-54622
    Diploma/Master Student
    Tessmar
    4.501
    Main Building
  • Matthew Clarke
    +43-1-4277-52808
    PhD Student
    Campbell
    5.512/5.513
    Main Building
  • Clara Conrad-Billroth
    +43-1-4277-52213
    PhD Student
    Juffmann
    1.614
    VBC 5
  • Aida Coric
    +43-1-4277-74636
    PhD Student
    Tessmar
    4.501
    Main Building
  • Nicolas Coudevylle
    +43-1-4277-52838
    PostDoc
    Martens
    5.401
    Main Building
  • Renate Coufal
    +43-1-4277-24071
    Facility Staff
    1.117
    Main Building
  • Kitti Dora Csalyi
    +43-1-4277-74645
    PostDoc
    Leeb
    3.123/3.125
    Main Building
  • Andrea Czerny
    +43-1-4277-61606
    Lab Assistant
    3.515
    Main Building
  • D
  • Alexander Dammermann
    +43-1-4277-54681
    Group Leader
    Dammermann
    4.609
    Main Building
  • Alberto Danieli
    +43-1-4277-52805
    PhD Student
    Martens
    5.503
    Main Building
  • Pauline Dao
    +43-1-4277-54618
    PhD Student
    Tessmar
    4.510/4.512
    Main Building
  • Lovro Davidovski
    +43-1-4277-54631
    Diploma/Master Student
    Bläsi
    4.122/4.124
    Main Building
  • Thomas Decker
    +43-1-4277-54605
    Group Leader
    Decker
    4.112
    Main Building
  • Isabel Del Pino Gomez
    +43-1-4277-54601
    Lab Assistant
    Bläsi
    4.211/4.411
    Main Building
  • Maria Rosaria Dello Stritto
    +43-1-4277-56261
    PostDoc
    Jantsch V
    5.522
    Main Building
  • Duygu Demiröz
    +43-1-4277-54628
    PhD Student
    Decker
    4.522/4.524
    Main Building
  • Sebastian Didusch
    +43-1-4277-54629
    PhD Student
    Baccarini
    4.525/4.527
    Main Building
  • Danijel Dilberovic
    +43-1-4277-61635
    Karagöz
    3.507/ 3.508
    Main Building
  • Ines Dittrich
    +43-1-4277-56241
    Technician
    5.524/5.526
    Main Building
  • Kristina Djinovic-Carugo
    +43-1-4277-52203
    Group Leader
    Djinovic
    1.606
    VBC 5
  • Paula Dlugosz
    +43-1-4277-61809
    PostDoc
    Nimpf
    2.110
    Main Building
  • Jeroen Dobbelaere
    +43-1-4277-54619
    PostDoc
    Dammermann
    4.510/4.512
    Main Building
  • Mihaela Dodaj
    +43-1-4277-24072
    Lab Assistant
    1.117
    Main Building
  • Gang Dong
    +43-1-4277-61625
    Group Leader
    Dong
    3.501
    Main Building
  • Coralie Dorard
    +43-1-4277-54630
    PostDoc
    Baccarini
    4.529
    Main Building
  • Corinne Drexler
    +43-1-4277-52866
    PhD Student
    Fuchs
    5.506
    Main Building
  • Sharif Duale
    +43-1-4277-61785
    Technician
    2.527
    Main Building
  • E
  • Cornelia Egoldt
    +43-1-4277-56241
    PhD Student
    Schlögelhofer
    5.524/5.526
    Main Building
  • Karin Ehrenreiter
    +43-1-4277-54617
    Administration
    Baccarini
    4.114
    Main Building
  • Janina Eislmayr
    +43-1-4277-54626
    Diploma/Master Student
    Kovarik
    4.516
    Main Building
  • Kevin Eislmayr
    +43-1-4277-54626
    PhD Student
    Kovarik
    4.516
    Main Building
  • Aybala Eker
    +43-1-4277-61812
    Lab Assistant
    Kuchler
    2.107
    Main Building
  • Christiane Elgert
    +43-1-4277-74325
    PostDoc
    v. Haeseler
    1.812.4
    VBC 5
  • Rainer Ettelt
    +43-1-4277-54630
    PhD Student
    Baccarini
    4.529
    Main Building
  • F
  • Martin Fahrenberger
    +43-1-4277-74330
    PhD Student
    v. Haeseler
    1.812.2
    VBC 5
  • Sebastian Falk
    +43-1-4277-74360
    Group Leader
    Falk
    1.622.1
    VBC 5
  • Renate Fauland
    +43-1-4277-50115
    Administration
    6.111a
    Main Building
  • Markus Faulend
    +43-1-4277-24043
    IT Support
    2.116
    Main Building
  • Michael Feichtinger
    +43-1-4277-52227
    PhD Student
    Konrat
    0614
    VBC 5
  • Simona Ferraioli
    +43-1-4277-61681
    PhD Student
    Foisner
    3.110
    Main Building
  • Luca Ferrari
    +43-1-4277-52828
    PostDoc
    Martens
    5.502
    Main Building
  • Inês Ferreira Coelho
    +43-1-4277-74320
    PhD Student
    v. Haeseler
    1.812.3
    VBC 5
  • Jeanne Fesselet
    +43-1-4277-54626
    Diploma/Master Student
    Kovarik
    4.516
    Main Building
  • Petra Fichtinger
    +43-1-4277-61681
    Lab Manager
    Foisner
    3.110
    Main Building
  • Daria Filipczak
    +43-1-4277-61681
    PhD Student
    Foisner
    3.110
    Main Building
  • Sarah Fink
    +43-1-4277-52808
    Technician
    Campbell
    5.512/5.513
    Main Building
  • Philipp Fischer
    +43-1-4277-54628
    Technician
    Decker
    4.525/4.527
    Main Building
  • Katrin Fischer
    +43-1-4277-54628
    PhD Student
    Decker
    4.522/4.524
    Main Building
  • Sabine Fischer
    +43-1-4277-24014
    Administration
    3.117
    Main Building
  • Irmgard Fischer
    +43-1-4277-52866
    Imaging Specialist (In House Microscopes)
    5.401
    Main Building
  • Roland Foisner
    +43-1-4277-61680
    Group Leader
    Foisner
    3.113
    Main Building
  • Dominic Földvári
    +43-1-4277-74320
    PhD Student
    v. Haeseler
    1.812.3
    VBC 5
  • Maurizio Forte
    +43-1-4277-54626
    PhD Student
    Kovarik
    4.516
    Main Building
  • Dorotea Fracchiolla
    +43-1-4277-52805
    PostDoc
    Martens
    5.502
    Main Building
  • Ingrid Frohner
    +43-1-4277-61740
    PostDoc
    Ogris
    2.130
    Main Building
  • Peter Fuchs
    +43-1-4277-52855
    Group Leader
    Fuchs
    5.024
    Main Building
  • Sándor Fülöp
    +43-1-4277-24013
    Administration
    3.117
    Main Building
  • G
  • Laura Gallego
    +43-1-4277-61641
    PostDoc
    Köhler A
    3.522
    Main Building
  • Kilian Gandolf
    +43-1-4277-56241
    Diploma/Master Student
    Schlögelhofer
    5.623
    Main Building
  • Joachim Garbrecht
    +43-1-4277-54621
    PhD Student
    Dammermann
    4.508
    Main Building
  • Julia Garcia Baucells
    +43-1-4277-24001
    PhD Student
    Dammermann
    4.508
    Main Building
  • Konstantina Georgiou
    +43-1-4277-61681
    PhD Student
    Foisner
    3.110
    Main Building
  • Clemens Geppner
    +43-1-4277-61668
    Diploma/Master Student
    Otsuka
    3.505
    Main Building
  • Flora Gere
    +43-1-4277-52828
    Diploma/Master Student
    Martens
    5.503
    Main Building
  • Gabriela Gerecova
    +43-1-4277-52806
    PostDoc
    Ammerer
    2.122
    Main Building
  • Devon Germain
    +43-1-4277-61823
    PostDoc
    Martinez
    2.515
    Main Building
  • Tanja Gesell
    +43-1-4277-52292
    1.610
    VBC 5
  • Netsanet Getachew
    +43-1-4277-74636
    Technician
    Tessmar
    4.501
    Main Building
  • Santhosh Kumar Ghadge
    +43-1-4277-61671
    PostDoc
    Foisner
    3.009
    Main Building
  • Marion Goldeck
    +43-1-4277-61816
    PostDoc
    Martinez
    2.512
    Main Building
  • Boris Görke
    +43-1-4277-54603
    Group Leader
    Görke
    4.113
    Main Building
  • Irene Gösler
    +43-1-4277-61632
    Lab Manager
    Blaas
    3.129
    Main Building
  • Josef Gotzmann
    +43-1-4277-61672
    Head of Facility
    1.618
    VBC 5
  • Angela Graf
    +43-1-4277-56261
    Technician
    Jantsch V
    5.522
    Main Building
  • Claudia Graf
    +43-1-4277-24012
    Administration
    6.109
    Main Building
  • Christa Gregori-Schüller
    +43-1-4277-61806
    PostDoc
    Kuchler
    2.111
    Main Building
  • Rokas Grigaitis
    +43-1-4277-56231
    PhD Student
    Matos
    5.122/5.123
    Main Building
  • Tamara Groffics
    +43-1-4277-61668
    Lab Manager
    Otsuka
    3.505
    Main Building
  • Martin Groznica
    +43-1-4277-61631
    Technician
    Kowalski
    3.126
    Main Building
  • Katarzyna Gruber
    +43-1-4277-24075
    Lab Assistant
    1.117
    Main Building
  • Iris Gruber
    +43-1-4277-74320
    Administration
    v. Haeseler
    1.604
    VBC 5
  • Stephan Grüner
    +43-1-4277-54628
    Technician
    Decker
    4.522/4.524
    Main Building
  • Ricardo Mauricio Gudino Carrillo
    +43-1-4277-61641
    Technician
    Köhler A
    3.522
    Main Building
  • Laila Gulijeva
    +43-1-4277-74644
    Diploma/Master Student
    Leeb
    3.123/3.125
    Main Building
  • H
  • Katharina Haberler
    +43-1-4277-56201
    Administration
    5.115
    Main Building
  • Kathrin Hacker
    +43-1-4277-54614
    Technician
    Versteeg
    4.108
    Main Building
  • Thomas Haden
    +43-1-4277-24042
    IT Support
    2.116
    Main Building
  • Simon Haendeler
    +43-1-4277-74329
    PhD Student
    v. Haeseler
    1.812.2
    VBC 5
  • Sören Häfker
    +43-1-4277-74641
    PostDoc
    Tessmar
    4.504/4.506
    Main Building
  • Anna Hakobyan
    +43-1-4277-74391
    PhD Student
    Menche
    1803
    VBC 5
  • Barbara Hamilton
    +43-1-4277-52814
    Administration
    6.111a
    Main Building
  • Iana Hammerschmid
    +43-1-4277-61626
    Dong
    3.502
    Main Building
  • Joel Hancock
    +43-1-4277-74391
    PhD Student
    Menche
    1803
    VBC 5
  • Buck Hanson
    +43-1-4277-74041
    Senior PostDoc
    Köhler A
    4624
    VBC 5
  • Robert Happel
    +43-1-4277-74322
    IT Support
    v. Haeseler
    1.812.1
    VBC 5
  • Andreas Hartig
    +43-1-4277- 52817
    Lecturer
    Hartig
    5.110
    Main Building
  • Natascha Hartl
    +43-1-4277-52846
    Technician
    5.10
    IMP/IMBA
  • Markus Hartl
    +43-1-4277-52846
    Head of Facility
    5.10
    IMP/IMBA
  • Lisa Haselbach
    +43-1-4277-61801
    Administration
    2.115
    Main Building
  • Adrian Henggeler
    +43-1-4277-56231
    PhD Student
    Matos
    5.122/5.123
    Main Building
  • Joachim Hermisson
    +43-1-4277-74351
    Group Leader
    Hermisson
    1.722.1
    VBC 5
  • Christian Hitzelhammer
    +43-1-4277-52272
    Zagrovic
    1.114
    VBC 5
  • Reinhold Hofbauer
    +43-1-4277-61750
    Group Leader
    Hofbauer
    2.519
    Main Building
  • Tatsiana Hofer
    +43-1-4277-74326
    PhD Student
    v. Haeseler
    1.812.5
    VBC 5
  • Juergen Hoffmann
    +43-1-4277-52213
    Technician
    1.620
    VBC 5
  • Michael Hoffmann
    +43-1-4277-52227
    Diploma/Master Student
    Konrat
    0614
    VBC 5
  • Theresa Höfurthner
    +43-1-4277-52263
    PhD Student
    Konrat
    0114
    VBC 5
  • Laurenz Holcik
    +43-1-4277-74325
    PhD Student
    v. Haeseler
    1.812.3
    VBC 5
  • Kay Holleis
    +43-1-4277-61656
    Diploma/Master Student
    Falk
    1.614
    VBC 5
  • David Hollenstein
    +43-1-4277-52838
    PhD Student
    Martens
    5.401
    Main Building
  • Eneda Höllerl
    +43-1-4277-52236
    Technician
    Djinovic
    0326
    VBC 5
  • Elisabeth Holzer
    +43-1-4277-54681
    Diploma/Master Student
    Dammermann
    4.510/4.512
    Main Building
  • Julian Holzinger
    +43-1-4277-52219
    PostDoc
    Konrat
    1.608
    VBC 5
  • Astrid Maria Hölzle
    +43-1-4277-74638
    Technician
    Bläsi
    4.116
    Main Building
  • Harald Hornegger
    +43-1-4277-61653
    PhD Student
    Karagöz
    3.507/ 3.508
    Main Building
  • Lingzhi Huang
    +43-1-4277-56221
    PostDoc
    Klein
    5.401
    Main Building
  • Marie Huber
    +43-1-4277-74647
    Technician
    Bücker
    3.510/3.512
    Main Building
  • Michelle Huth
    +43-1-4277-74644
    Technician
    Leeb
    3.123/3.125
    Main Building
  • Christiane Hütter
    +43-1-4277-74390
    Staff Scientist
    Menche
    1803
    VBC 5
  • I
  • Kyojiro Ikeda
    +43-1-4277-74636
    PostDoc
    Raible
    4.501
    Main Building
  • Johanna Irnstorfer
    +43-1-4277-61823
    Diploma/Master Student
    Martinez
    2.512
    Main Building
  • Natale-Erwin Ivessa
    +43-1-4277-61805
    Lecturer
    Ivessa
    2.118
    Main Building
  • J
  • Verena Jantsch-Plunger
    +43-1-4277-56250
    Group Leader
    Jantsch V
    5.118
    Main Building
  • Swathi Jayaram
    +43-1-4277-74646
    PhD Student
    Bücker
    3.510/3.512
    Main Building
  • Sabrina Jenull
    +43-1-4277-61818
    PostDoc
    Kuchler
    2.509
    Main Building
  • Aleksandra Jovanovic
    +43-1-4277-52806
    Lab Manager
    Ammerer
    2.122
    Main Building
  • Thomas Juffmann
    +43-1-4277-72520
    Group Leader
    Juffmann
    1.610
    VBC 5
  • Melanie Jungwirth
    +43-1-4277-52236
    Diploma/Master Student
    Djinovic
    0326
    VBC 5
  • Elisabeth Jursa
    +43-1-4277-52875
    Lab Assistant
    5.325
    Main Building
  • K
  • Kristoffer Kainzmayer
    +43-1-4277-54606
    Diploma/Master Student
    Moll
    4.028
    Main Building
  • Thomas Kapral
    +43-1-4277-52272
    Technician
    Zagrovic
    1.114
    VBC 5
  • Elif Karagöz
    +43-1-4277-61635
    Group Leader
    Karagöz
    3.507/ 3.508
    Main Building
  • Ruben Kastner
    +43-1-4277-56241
    Apprentice
    Schlögelhofer
    5.524/5.526
    Main Building
  • Clemens Kauffmann
    +43-1-4277-52292
    PhD Student
    Konrat
    0614
    VBC 5
  • Helga Kaufmann
    +43-1-4277-52801
    Lab Assistant
    5.210/5.410
    Main Building
  • Tanja Kaufmann
    +43-1-4277-52807
    PhD Student
    Slade
    5.508
    Main Building
  • Paulina Kettel
    +43-1-4277-61653
    PhD Student
    Karagöz
    3.507/ 3.508
    Main Building
  • Muna Ayesha Khan
    +43-1-4277-74610
    PostDoc
    Moll
    4.110
    Main Building
  • AMEYA RAKESH KHANDEKAR
    +43-1-4277-61823
    PhD Student
    Martinez
    2.512
    Main Building
  • Sami Khawam
    +43-1-4277-74320
    PostDoc
    Juffmann
    1.610
    VBC 5
  • Narakorn Khunweeraphong
    +43-1-4277-61818
    PostDoc
    Kuchler
    2.509
    Main Building
  • Martin Kiendl
    +43-1-4277-52236
    Diploma/Master Student
    Djinovic
    0326
    VBC 5
  • Lukas Kienesberger
    +43-1-4277-74320
    Juffmann
    1.812.3
    VBC 5
  • SEYDA KIGILI
    +43-1-4277-54613
    Diploma/Master Student
    Witte
    4.125/4.127
    Main Building
  • Franz Klein
    +43-1-4277-56220
    Group Leader
    Klein
    5.114
    Main Building
  • Ava Kleinwaechter
    +43-1-4277-52807
    Diploma/Master Student
    Slade
    5.508
    Main Building
  • Tamara Klockner
    +43-1-4277-52808
    PhD Student
    Campbell
    5.512/5.513
    Main Building
  • Alwin Köhler
    +43-1-4277-61685
    Group Leader
    Köhler A
    3.626
    Main Building
  • Dhaarsini Koneswarakantha
    +43-1-4277-61821
    PhD Student
    Martinez
    2.515
    Main Building
  • Werner König
    +43-1-4277-52210
    Technician
    1.620
    VBC 5
  • Robert Konrat
    +43-1-4277-52202
    Group Leader
    Konrat
    1.602
    VBC 5
  • Georg Kontaxis
    +43-1-4277-52218
    Facility Manager
    1.608
    VBC 5
  • Katharina Korbula
    +43-1-4277-61626
    Lab Manager
    Dong
    3.501
    Main Building
  • Julius Kostan
    +43-1-4277-52263
    Senior PostDoc
    Djinovic
    0114
    VBC 5
  • Pavel Kovarik
    +43-1-4277-54608
    Group Leader
    Kovarik
    4.615
    Main Building
  • Heinrich Kowalski
    +43-1-4277-61612
    Group Leader
    Kowalski
    3.026
    Main Building
  • Felix Krepler
    +43-1-4277-24065
    Technician
    3.501
    Main Building
  • Karl Kuchler
    +43-1-4277-61807
    Group Leader
    Kuchler
    2.111
    Main Building
  • Claudia Kuntner
    +43-1-4277-56221
    Klein
    5.528/5.530
    Main Building
  • Marie-Therese Kurzbauer
    +43-1-4277-56202
    Program manager
    Schlögelhofer
    5.119
    Main Building
  • L
  • Triin Laos
    +43-1-4277-54621
    PhD Student
    Dammermann
    4.508
    Main Building
  • Anita Le Heron
    +43-1-4277-54626
    PostDoc
    Kovarik
    4.516
    Main Building
  • Karin Ledolter
    +43-1-4277-52260
    Lab Manager
    Konrat
    0122
    VBC 5
  • Martin Leeb
    +43-1-4277-74644
    Group Leader
    Leeb
    3.123/3.125
    Main Building
  • Lena Leifert
    +43-1-4277-61656
    Falk
    1.624
    VBC 5
  • Günther Leitgeb
    +43-1-4277-54633
    IT Management
    4.420
    Main Building
  • Moritz Leitner
    +43-1-4277-61816
    Martinez
    2.512
    Main Building
  • Thomas Lenert
    +43-1-4277-61602
    Administration
    3.115
    Main Building
  • Thomas Leonard
    +43-1-4277-52205
    Group Leader
    Leonard
    1.616
    VBC 5
  • Alina Leuchtenberger
    +43-1-4277-74330
    PhD Student
    v. Haeseler
    1.812.2
    VBC 5
  • Aleksandra Levina
    +43-1-4277-52275
    PhD Student
    Leonard
    1.321
    VBC 5
  • Raffael Lichtenberger
    +43-1-4277-61656
    Technician
    Falk
    1.624
    VBC 5
  • Branislav Lilic
    +43-1-4277-54631
    PhD Student
    Bläsi
    4.122/4.124
    Main Building
  • Eszter Lodinsky
    +43-1-4277-52263
    Diploma/Master Student
    Djinovic
    0114
    VBC 5
  • Josef Loidl
    +43-1-4277-56210
    Group Leader
    Loidl
    5.515
    Main Building
  • Salvo Danilo Lombardo
    +43-1-4277-74390
    PhD Student
    Menche
    1803
    VBC 5
  • Joan Lopez Arolas
    +43-1-4277-52225
    Senior PostDoc
    Djinovic
    0612
    VBC 5
  • Francesca Lorant
    +43-1-4277-5108
    Diploma/Master Student
    Bachmair
    5.108/5.109
    Main Building
  • M
  • Moritz Madern
    +43-1-79044-4291
    Technician
    5.10
    IMP/IMBA
  • Silvia Madritsch
    +43-1-4277-74324
    PhD Student
    v. Haeseler
    1.812.4
    VBC 5
  • Dante Maestre
    +43-1-4277-52213
    PhD Student
    Juffmann
    1.722
    VBC 5
  • Daniel Malzl
    +43-1-4277-74390
    PhD Student
    Menche
    1803
    VBC 5
  • Christina Manakanatas
    +43-1-4277-74644
    PhD Student
    Foisner
    3.123/3.125
    Main Building
  • Richard Manning
    +43-1-4277-54613
    Diploma/Master Student
    Witte
    4.125/4.127
    Main Building
  • Toni Manolova
    +43-1-4277-61656
    Diploma/Master Student
    Falk
    1.624
    VBC 5
  • Raphaël Marchand
    +43-1-4277-72523
    PostDoc
    Juffmann
    1.614
    VBC 5
  • Theodor Marsoner
    +43-1-4277-52808
    PhD Student
    Campbell
    5.512/5.513
    Main Building
  • Sascha Martens
    +43-1-4277-52876
    Group Leader
    Martens
    5.113
    Main Building
  • Javier Martinez
    +43-1-4277-61803
    Group Leader
    Martinez
    2.113
    Main Building
  • Fabien Martins
    +43-1-4277-24010
    Financial Director
    6.107
    Main Building
  • Angela Martins
    +43-1-4277-54601
    Administration
    4.114
    Main Building
  • Lejla Mastalic
    +43-1-4277-74645
    Diploma/Master Student
    Leeb
    3.123/3.125
    Main Building
  • Joao Matos
    +43-1-4277-74419
    Group Leader
    Matos
    5.024
    Main Building
  • Theresa Matzinger
    +43-1-4277-61761
    Weitzer
    2.522
    Main Building
  • Rounik Mazumdar
    +43-1-4277-61818
    PostDoc
    Kuchler
    2.509
    Main Building
  • Jörg Menche
    +43-1-4277-74370
    Group Leader
    Menche
    1804
    VBC 5
  • Julian Merio
    +43-1-4277-61668
    Otsuka
    3.505
    Main Building
  • Tim Michelberger
    +43-1-4277-61641
    Diploma/Master Student
    Köhler A
    3.522
    Main Building
  • Mario Migotti
    +43-1-4277-52263
    PhD Student
    Konrat
    0114
    VBC 5
  • Dalibor Milic
    +43-1-4277-52215
    Senior PostDoc
    Djinovic
    1.120
    VBC 5
  • Frane Miljkovic
    +43-1-4277-61643
    PhD Student
    Köhler A
    3.524
    Main Building
  • Milana Mirkovic
    +43-1-4277-52272
    Diploma/Master Student
    Zagrovic
    1.114
    VBC 5
  • Alexandru-Stefan Mixich
    +43-1-4277-24042
    IT Support
    2.116
    Main Building
  • Georg Mlynek
    +43-1-4277-52263
    PostDoc
    Djinovic
    0114
    VBC 5
  • Katharina Mohr
    +43-1-4277-61704
    Technician
    Ogris
    2.127
    Main Building
  • Isabella Moll
    +43-1-4277-54606
    Group Leader
    Moll
    4.028
    Main Building
  • Luisa Morelli
    +43-1-4277-54626
    Technician
    Kovarik
    4.516
    Main Building
  • Anna-Marina Mrak
    +43-1-4277-52272
    Technician
    Zagrovic
    1.321
    VBC 5
  • Ingrid Mudrak
    +43-1-4277-61740
    Lab Manager
    Ogris
    2.030
    Main Building
  • Christian Müller
    +43-1-4277-54613
    PhD Student
    Moll
    4.125/4.127
    Main Building
  • Ernst Müllner
    +43-1-4277-61783
    Group Leader
    Müllner
    2.523
    Main Building
  • N
  • Nana Naetar-Kerenyi
    +43-1-4277-61671
    PostDoc
    Foisner
    3.108
    Main Building
  • Michael Nagy
    +43-1-4277-52263
    Diploma/Master Student
    Djinovic
    0114
    VBC 5
  • Kuldeep Nangalia
    +43-1-4277-56221
    Klein
    5.528/5.530
    Main Building
  • Marintia Mayola Nava Garcia
    +43-1-4277-61649
    PhD Student
    Köhler A
    3.527
    Main Building
  • Lilian Nehlin
    +43-1-4277-52810
    PostDoc
    Bachmair
    5.108/5.109
    Main Building
  • Mandy Neumann
    +43-1-4277-74610
    PhD Student
    Görke
    4.110
    Main Building
  • Tobias Nimpf
    +43-1-4277-61810
    Lab Assistant
    Foisner
    3.108
    Main Building
  • Johannes Nimpf
    +43-1-4277-61808
    Group Leader
    Nimpf
    2.112
    Main Building
  • Adrian Nogales Moral
    +43-1-4277-61643
    PhD Student
    Köhler A
    3.524
    Main Building
  • Filomena Nogueira
    +43-1-4277-61817
    PostDoc
    Kuchler
    2.505
    Main Building
  • O
  • Egon Ogris
    +43-1-4277-61730
    Group Leader
    Ogris
    2.127
    Main Building
  • Cornelia Oppitz
    +43-1-4277-74640
    Program manager
    Baccarini
    4.116
    Main Building
  • Lukas Orel
    +43-1-4277-74636
    Lab Manager
    Tessmar
    4.501
    Main Building
  • Lucija Orlić
    +43-1-4277-56231
    PhD Student
    Matos
    5.122/5.123
    Main Building
  • Ana Orsolic
    +43-1-4277-52236
    Diploma/Master Student
    Djinovic
    0326
    VBC 5
  • Shotaro Otsuka
    +43-1-4277-61665
    Group Leader
    Otsuka
    3.506
    Main Building
  • Ö
  • Sidar Özer
    +43-1-4277-24042
    IT Support
    2.116
    Main Building
  • P
  • Claudia Pachinger
    +43-1-4277-54621
    PhD Student
    Dammermann
    4.508
    Main Building
  • Nathan Palmer
    +43-1-4277-56231
    PostDoc
    Matos
    5.122/5.123
    Main Building
  • Dimitra Paouneskou
    +43-1-4277-56261
    PostDoc
    Jantsch V
    5.522
    Main Building
  • Lara Lucija Paparic
    +43-1-4277-74610
    Diploma/Master Student
    Görke
    4.110
    Main Building
  • Paulina Parafiniuk-Borzecki
    +43-1-4277-52801
    Administration
    5.115
    Main Building
  • Djurdja Pasajlic
    +43-1-4277-61823
    PhD Student
    Martinez
    2.515
    Main Building
  • Julia Pazmandi
    +43-1-4277-74391
    PhD Student
    Menche
    1104
    VBC 5
  • Maximilian Peer
    +43-1-4277-61626
    Diploma/Master Student
    Dong
    3.501
    Main Building
  • Philipp Penninger
    +43-1-4277-61812
    PhD Student
    Kuchler
    2.107
    Main Building
  • Cassius Manuel Perez de los Cobos Hermosa
    +43-1-4277-74326
    PhD Student
    v. Haeseler
    1.812.5
    VBC 5
  • Thomas Peterbauer
    +43-1-4277-61676
    Senior Imaging Specialist
    1.618
    VBC 5
  • Vicky Petroulaki
    +43-1-4277-56231
    PhD Student
    Matos
    5.122/5.123
    Main Building
  • Andriy Petryshyn
    +43-1-4277-61812
    Technician
    Kuchler
    2.107
    Main Building
  • Franz Pfanner
    +43-1-4277-74320
    Juffmann
    1.812.3
    VBC 5
  • Karin Pfeiffer
    +43-1-4277-52201
    Administration
    1.604
    VBC 5
  • Florian Pflug
    +43-1-4277-74323
    PostDoc
    v. Haeseler
    1.812.1
    VBC 5
  • Parvaneh Piran
    +43-1-4277-24004
    Administration
    6.109
    Main Building
  • Sebastian Pirch
    +43-1-4277-74391
    Technician
    Menche
    1803
    VBC 5
  • Ekaterini Platanitis
    +43-1-4277-54628
    PostDoc
    Decker
    4.525/4.527
    Main Building
  • Gerald Platzer
    +43-1-4277-52227
    PostDoc
    Konrat
    0614
    VBC 5
  • Marina Pletzer
    +43-1-4277-61656
    PhD Student
    Falk
    1.624
    VBC 5
  • Elke Podgorschek
    +43-1-4277-54628
    Diploma/Master Student
    Decker
    4.522/4.524
    Main Building
  • Birgit Poehn
    +43-1-4277-74636
    PhD Student
    Tessmar
    4.501
    Main Building
  • Daniel Pokorný
    +43-1-4277-52241
    PhD Student
    Leonard
    1.321.1
    VBC 5
  • Miroslav Poláček
    +43-1-4277-74320
    Technician
    Swarts
    1.722.1
    VBC 5
  • Anton Polyansky
    +43-1-4277-52271
    Staff Scientist
    Zagrovic
    1.612
    VBC 5
  • Hauptgebäude Portier
    +43-1-4277-12894
    1.106
    Main Building
  • Viktoria Prast
    +43-1-4277-56221
    PhD Student
    Klein
    5.401
    Main Building
  • Silvia Prieler
    +43-1-4277-56221
    PostDoc
    Klein
    5.401
    Main Building
  • Günther Prohaczka
    +43-1-4277-74636
    Diploma/Master Student
    Tessmar
    4.501
    Main Building
  • Friedrich Propst
    +43-1-4277-52858
    Guest Researcher
    Propst
    5.528/5.530
    Main Building
  • Ignacio Prusén
    +43-1-4277-56241
    PhD Student
    Schlögelhofer
    5.524/5.526
    Main Building
  • Sylvia Prutti
    +43-1-4277-24001
    Administration
    6.108
    Main Building
  • Dominic Pühringer
    +43-1-4277-52225
    PhD Student
    Djinovic
    0612
    VBC 5
  • Q
  • Yue Qiu
    +43-1-4277-56201
    Diploma/Master Student
    Martens
    5.503
    Main Building
  • Laura Quell
    +43-1-4277-74610
    Diploma/Master Student
    Görke
    4.110
    Main Building
  • R
  • Stefan Rabong
    +43-1-4277-61822
    Diploma/Master Student
    Ivessa
    2.504
    Main Building
  • Katarina Radisavljevic
    +43-1-4277-61641
    PhD Student
    Köhler A
    3.522
    Main Building
  • Florian Raible
    +43-1-4277-54616
    Group Leader
    Raible
    4.115
    Main Building
  • Vinod Rajendra
    +43-1-4277-56220
    PostDoc
    Klein
    5.114
    Main Building
  • Julia Ramesmayer
    +43-1-4277-74645
    Lab Manager
    Leeb
    3.123/3.125
    Main Building
  • Birgit Rapp
    +43-1-4277-54628
    Lab Manager
    Decker
    4.522/4.524
    Main Building
  • Eva Rasch
    +43-1-4277-52820
    Facility Technician
    5.116
    Main Building
  • Sonia Ratajczyk
    +43-1-4277-52862
    PhD Student
    Fuchs
    5.125/5.127
    Main Building
  • Aarathy Ravi sundar Jose Geetha
    +43-1-4277-54628
    PhD Student
    Decker
    4.522/4.524
    Main Building
  • Mihaela Raykova
    +43-1-4277-61653
    Diploma/Master Student
    Karagöz
    3.507/ 3.508
    Main Building
  • Antonio Real-Hohn
    +43-1-4277-61631
    PostDoc
    Blaas
    3.127
    Main Building
  • Elisabeth Rebhan
    +43-1-4277-54629
    Diploma/Master Student
    Baccarini
    4.525/4.527
    Main Building
  • Michael Rechberger
    +43-1-4277-61653
    Diploma/Master Student
    Karagöz
    3.507/ 3.508
    Main Building
  • Ronja Reinhardt
    +43-1-4277-52275
    PhD Student
    Leonard
    1.321
    VBC 5
  • Wolfgang Ludwig Reiter
    +43-1-4277-52846
    PostDoc
    5.10
    IMP/IMBA
  • Lena Reitinger
    +43-1-4277-52272
    Zagrovic
    1.114
    VBC 5
  • Armin Resch
    +43-1-4277-54631
    Lab Manager
    Bläsi
    4.122/4.124
    Main Building
  • Roger Revilla-i-Domingo
    +43-1-4277-54618
    PostDoc
    Raible
    4.510/4.512
    Main Building
  • Ramia Rez
    +43-1-4277-90667746132343
    Technician
    Köhler A
    4624
    VBC 5
  • Julia Riefler
    +43-1-79044-9942
    Lab Manager
    Swarts
    1.722.1
    VBC 5
  • Marianne Rocha Hasler
    +43-1-4277-52201
    Technician Vienna COVID-19 Detection Initiative
    Köhler A
    4620
    VBC 5
  • Dunja Rokvic
    +43-1-4277-74636
    Technician
    Tessmar
    4.501
    Main Building
  • Anete Romanauska
    +43-1-4277-61649
    PostDoc
    Köhler A
    3.527
    Main Building
  • Julia Romanov
    +43-1-4277-52805
    Lab Manager
    Martens
    5.502
    Main Building
  • Merrit Romeike
    +43-1-4277-74647
    PhD Student
    Bücker
    3.510/3.512
    Main Building
  • Nathalie Ropek
    +43-1-4277-74040
    Technician
    Köhler A
    4624
    VBC 5
  • Dagmar Roschitz
    +43-1-4277-24072
    Facility Staff
    1.117
    Main Building
  • Katrin Rose
    +43-1-4277-52810
    Diploma/Master Student
    Bachmair
    5.108/5.109
    Main Building
  • Johann Rotheneder
    +43-1-4277-61720
    Lecturer
    Rotheneder
    2.125
    Main Building
  • Claudia Rudolf
    +43-1-4277-61761
    Apprentice
    Weitzer
    2.522
    Main Building
  • Cornelia Rumpf-Kienzl
    +43-1-4277-54619
    PostDoc
    Dammermann
    4.510/4.512
    Main Building
  • Harald Rumpler
    +43-1-4277-61810
    Technician
    Nimpf
    2.110
    Main Building
  • S
  • Sowmya S Geetha
    +43-1-4277-56250
    PhD Student
    Jantsch V
    5.522
    Main Building
  • Carolina Saad
    +43-1-4277-56241
    PhD Student
    Schlögelhofer
    5.524/5.526
    Main Building
  • Dunia Sahir
    +43-1-4277-52236
    Diploma/Master Student
    Djinovic
    0326
    VBC 5
  • Ulrich Salzer
    +43-1-4277-61669
    PostDoc
    Müllner
    2.523
    Main Building
  • Laura Santini
    +43-1-4277-74645
    PhD Student
    Leeb
    3.123/3.125
    Main Building
  • Thomas Sauer
    +43-1-4277-61782
    Facility Manager
    2.126
    Main Building
  • Adriana Savova
    +43-1-4277-52805
    PhD Student
    Martens
    5.503
    Main Building
  • Justyna Sawa-Makarska
    +43-1-4277-52805
    PostDoc
    Martens
    5.502
    Main Building
  • Sonja Schauer
    +43-1-4277-56241
    Apprentice
    Schlögelhofer
    5.524/5.526
    Main Building
  • Natascha Scherzer
    +43-1-4277-24072
    Facility Staff
    1.117
    Main Building
  • Alexandra Schilder
    +43-1-4277-74610
    PhD Student
    Görke
    4.110
    Main Building
  • Marco Schindler
    +43-1-4277-5109
    Diploma/Master Student
    5.108/5.109
    Main Building
  • Peter Schlögelhofer
    +43-1-4277-56240
    Group Leader
    Schlögelhofer
    5.623
    Main Building
  • Julia Schmid
    +43-1-4277-52808
    Campbell
    5.512/5.513
    Main Building
  • Heiko Schmidt
    +43-1-4277-74321
    Senior PostDoc
    v. Haeseler
    1.812.1
    VBC 5
  • Marketa Schmidt Cernohorska
    +43-1-4277-54619
    PostDoc
    Dammermann
    4.508
    Main Building
  • Maren Schneider
    +43-1-4277-61643
    Staff Scientist
    Köhler A
    3.524
    Main Building
  • Matthias Schneller
    +43-1-4277-52213
    Diploma/Master Student
    Juffmann
    1.614
    VBC 5
  • Šárka Schořová
    +43-1-4277-56241
    PostDoc
    Schlögelhofer
    5.524/5.526
    Main Building
  • Vera Schoft
    +43-1-4277-7272
    1. OG 06
    VBC 2
  • Julia Scholz
    +43-1-4277-61668
    Otsuka
    3.505
    Main Building
  • Claudia Schreiner
    +43-1-4277-52233
    Lab Manager
    Djinovic
    0124
    VBC 5
  • Dominik Schrempf
    +43-1-4277-74328
    PostDoc
    v. Haeseler
    1.812.3
    VBC 5
  • Renée Schroeder
    +43-1-4277-54690
    Group Leader
    Schroeder
    5.113
    Main Building
  • Stefan Schuechner
    +43-1-4277-61731
    PostDoc
    Ogris
    2.127
    Main Building
  • Martina Schuschnig
    +43-1-4277-52838
    Technician
    Martens
    5.401
    Main Building
  • Maximilian Schwab
    +43-1-4277-61810
    Diploma/Master Student
    Nimpf
    2.110
    Main Building
  • Irene Schwartz
    +43-1-4277-54614
    PhD Student
    Versteeg
    4.108
    Main Building
  • Thomas Schwarz
    +43-1-4277-52263
    PostDoc
    Konrat
    0114
    VBC 5
  • Alois Schweighofer
    +43-1-4277-76528
    6.111a
    Main Building
  • Nina Schweitzer
    +43-1-4277-54630
    Technician
    Baccarini
    4.529
    Main Building
  • Sara Scinicariello
    +43-1-4277-54164
    PhD Student
    Versteeg
    4.108
    Main Building
  • Michaela Sekljic
    +43-1-4277-24001
    Administration
    6.108
    Main Building
  • Mehrta Shirzadian
    +43-1-79044-9942
    PhD Student
    Swarts
    1.722.1
    VBC 5
  • Alexandra Shulkina
    +43-1-4277-54614
    PhD Student
    Versteeg
    4.108
    Main Building
  • Dhanlakshmi Shunmugam
    +43-1-4277-54629
    PhD Student
    Baccarini
    4.529
    Main Building
  • Katharina Siess
    +43-1-4277-52241
    PhD Student
    Leonard
    1.222
    VBC 5
  • Florian Sikora
    +43-1-4277-74610
    PhD Student
    Görke
    4.110
    Main Building
  • Lidia Silva
    +43-1-4277-54625
    PostDoc
    Kovarik
    4.514
    Main Building
  • Jason Sims
    +43-1-4277-56241
    PostDoc
    Schlögelhofer
    5.524/5.526
    Main Building
  • Celine Sin
    +43-1-4277-74391
    PostDoc
    Menche
    1803
    VBC 5
  • Tim Skern
    +43-1-4277-61620
    Group Leader
    Skern
    3.118
    Main Building
  • Dea Slade
    +43-1-4277-52811
    Group Leader
    Slade
    5.610
    Main Building
  • Melanie Slezak
    +43-1-4277-24072
    Facility Staff
    1.117
    Main Building
  • Georg Smesnik
    +43-1-4277-54628
    Diploma/Master Student
    Decker
    4.525/4.527
    Main Building
  • Adrian Söderholm
    +43-1-4277-54614
    PhD Student
    Versteeg
    4.108
    Main Building
  • Mate Somlyay
    +43-1-4277-52227
    PostDoc
    Konrat
    0614
    VBC 5
  • Elisabeth Sonnleitner
    +43-1-4277-54613
    Lecturer
    Bläsi
    4.125/4.127
    Main Building
  • Dieter Spittersberger
    +43-1-4277-56261
    Technician
    1. OG 10
    VBC 2
  • Antonio Sponga
    +43-1-4277-52236
    PhD Student
    Djinovic
    0326
    VBC 5
  • Rita Stadler
    +43-1-4277-56200
    Administration
    5.115
    Main Building
  • Alexander Stadler
    +43-1-4277-61626
    Dong
    3.502
    Main Building
  • Edvinas Stankunas
    +43-1-4277-61649
    Diploma/Master Student
    Köhler A
    3.527
    Main Building
  • Sonja Steindl
    +43-1-79044-
    Diploma/Master Student
    Swarts
    1.722.1
    VBC 5
  • Emma Stepinac
    +43-1-4277-54621
    Technician
    Dammermann
    4.508
    Main Building
  • Alexander Stockinger
    +43-1-4277-74636
    PhD Student
    Raible
    4.501
    Main Building
  • Anton Stoiber
    +43-1-4277-61818
    Technician
    Kuchler
    2.509
    Main Building
  • Johanna Stranner
    +43-1-4277-52857
    Technician
    5.116
    Main Building
  • Julia Straßer
    +43-1-4277-56261
    Diploma/Master Student
    Jantsch V
    5.522
    Main Building
  • Xue Strobl
    +43-1-4277-52811
    PhD Student
    Slade
    5.508
    Main Building
  • Tiffany Su
    +43-1-4277-54621
    PostDoc
    Dammermann
    4.508
    Main Building
  • Kelly Swarts
    +43-1-4277-74320
    Group Leader
    Swarts
    1.722
    VBC 5
  • Julian Szalay
    +43-1-4277-9069919922606
    Diploma/Master Student
    Witte
    4.125/4.127
    Main Building
  • T
  • Midori Takeda
    +43-1-4277-61649
    Technician
    Köhler A
    3.527
    Main Building
  • Markus Teige
    +43-1-4277-57719
    Lecturer
    5.110
    Main Building
  • Kristin Teßmar-Raible
    +43-1-4277-74635
    Group Leader
    Tessmar
    4.117
    Main Building
  • Magdalena Teufl
    +43-1-4277-61809
    Diploma/Master Student
    Nimpf
    2.110
    Main Building
  • Henry Thomas
    +43-1-4277-74647
    PhD Student
    Bücker
    3.510/3.512
    Main Building
  • Miao Tian
    +43-1-4277-56251
    PostDoc
    Loidl
    5.515
    Main Building
  • Stefanie Toifl
    +43-1-4277-54630
    PhD Student
    Baccarini
    4.529
    Main Building
  • Fotima Touraeva
    +43-1-4277-
    Technician
    Decker
    4.522/4.524
    Main Building
  • Riccardo Trapannone
    +43-1-4277-52838
    PostDoc
    Martens
    5.401
    Main Building
  • Linda Trübestein
    +43-1-4277-52241
    PostDoc
    Leonard
    1.222
    VBC 5
  • Michael Tscherner
    +43-1-4277-61818
    Kuchler
    2.509
    Main Building
  • Irina Tsymala
    +43-1-4277-61811
    PhD Student
    Kuchler
    2.107
    Main Building
  • Eleonora Turco
    +43-1-4277-52805
    PostDoc
    Martens
    5.503
    Main Building
  • Çağın Tüzün
    +43-1-4277-74320
    v. Haeseler
    1.812.2
    VBC 5
  • U
  • Amol Ugale
    +43-1-4277-54629
    PostDoc
    Baccarini
    4.529
    Main Building
  • Patricia Ulm
    +43-1-4277-56261
    Diploma/Master Student
    Jantsch V
    5.522
    Main Building
  • V
  • Karim Pyarali Vadiwala
    +43-1-4277-74636
    PhD Student
    Raible
    4.50
    IMP/IMBA
  • Miguel Vallebueno
    +43-1-79044-9000
    PostDoc
    Swarts
    1.722.1
    VBC 5
  • Steffi Varghese
    +43-1-4277-52215
    Diploma/Master Student
    Djinovic
    1.120
    VBC 5
  • Gina Varnavides
    +43-1-4277-24001
    Student assistant
    5.10
    IMP/IMBA
  • Vinoth Babu Veedin Rajan
    +43-1-4277-74641
    PostDoc
    Tessmar
    4.504/4.506
    Main Building
  • Jiri Veis
    +43-1-4277-52826
    PostDoc
    Ogris
    2.122
    Main Building
  • Maria Velkova
    +43-1-4277-56261
    PhD Student
    Jantsch V
    5.522
    Main Building
  • Gijs Versteeg
    +43-1-4277-54637
    Group Leader
    Versteeg
    4.009
    Main Building
  • Magdalena Vesely
    +43-1-4277-56221
    Technician
    Klein
    5.528/5.530
    Main Building
  • Isabella Völkl
    +43-1-4277-74647
    PhD Student
    Bücker
    3.510/3.512
    Main Building
  • Arndt von Haeseler
    +43-1-4277-74307
    Group Leader
    v. Haeseler
    1.107
    VBC 5
  • Denise Vorauer
    +43-1-4277-24072
    Facility Staff
    1.117
    Main Building
  • Georg Vucak
    +43-1-4277-54629
    PhD Student
    Baccarini
    4.525/4.527
    Main Building
  • Loan Vulliard
    +43-1-4277-74391
    PhD Student
    Menche
    1803
    VBC 5
  • Milica Vunjak
    +43-1-4277-54614
    PhD Student
    Versteeg
    4.108
    Main Building
  • W
  • Lena Walch
    +43-1-4277-52807
    Diploma/Master Student
    Slade
    5.508
    Main Building
  • Monika Waldherr
    +43-1-4277-74636
    Lab Manager
    Raible
    4.501
    Main Building
  • Laxmikant Wali
    +43-1-4277-4.125
    Diploma/Master Student
    Witte
    4.125/4.127
    Main Building
  • Philipp Weber
    +43-1-4277-72523
    PostDoc
    Juffmann
    1.614
    VBC 5
  • Lisa Weidlich
    +43-1-4277-74320
    Diploma/Master Student
    Swarts
    1.722.1
    VBC 5
  • Stefan Weitzer
    +43-1-4277-61815
    PostDoc
    Martinez
    2.512
    Main Building
  • Georg Weitzer
    +43-1-4277-61717
    Group Leader
    Weitzer
    2.118
    Main Building
  • Rahel Wettstein
    +43-1-4277-56231
    Senior PostDoc
    Matos
    5.122/5.123
    Main Building
  • Faye Wheeler
    +43-1-4277-56241
    PhD Student
    Schlögelhofer
    5.524/5.526
    Main Building
  • Gerhard Wiche
    +43-1-4277-52852
    Lecturer
    Wiche
    5.028
    Main Building
  • Helga Wieltschnig
    +43-1-4277-61701
    Administration
    2.115
    Main Building
  • Nikola Winter
    +43-1-4277-52810
    PostDoc
    Bachmair
    5.108/5.109
    Main Building
  • Sabina Winter
    +43-1-4277-61601
    Administration
    3.115
    Main Building
  • Angela Witte
    +43-1-4277-54643
    Group Leader
    Witte
    4.128
    Main Building
  • Anna Wunder
    +43-1-4277-52811
    Slade
    5.508
    Main Building
  • Bernhard Wurzinger
    +43-1-4277-52810
    PostDoc
    Bachmair
    5.108/5.109
    Main Building
  • X
  • Martin Xaver
    +43-1-4277-56221
    PhD Student
    Klein
    5.401
    Main Building
  • Y
  • Gülsüm Yilmaz
    +43-1-4277-54630
    Diploma/Master Student
    Baccarini
    4.529
    Main Building
  • Ivan Yudushkin
    +43-1-4277-74340
    Lecturer
    Yudushkin
    1.612
    VBC 5
  • Priyadarshini Yumnam
    +43-1-4277-56221
    PostDoc
    Loidl
    5.515
    Main Building
  • Z
  • Bojan Zagrovic
    +43-1-4277-52271
    Group Leader
    Zagrovic
    1.601
    VBC 5
  • Theresa Zekoll
    +43-1-4277-54622
    PhD Student
    Tessmar
    4.501
    Main Building
  • Madeleine Beatrice Zillner
    +43-1-4277-74636
    Diploma/Master Student
    Raible
    4.504/4.506
    Main Building
  • Martin Zurl
    +43-1-4277-54622
    PhD Student
    Raible
    4.504/4.506
    Main Building
  • Anna Zvereva
    +43-1-4277-52810
    PostDoc
    5.108/5.109
    Main Building
  • Daniela Zwolanek
    +43-1-4277-61831
    Lab Manager
    Martinez
    2.515
    Main Building

office@maxperutzlabs.ac.at

+43 1 4277 240 01
Today: 9am - 5pm

Vienna Biocenter (VBC)
Dr.-Bohr-Gasse 9, 1030 Vienna

Diese Seite ist auf Deutsch verfügbar. Zur deutschen Version.

COVID-19 Q&A’s

The Science behind COVID-19

Introduction

We are in the midst of the global COVID-19 pandemic, a severe respiratory disease caused by a Coronavirus called SARS-CoV-2. For a virus to cause a human pandemic, two conditions need to be met: the virus can be efficiently transmitted between humans and there is no pre-existing immunity against the new virus in the human population. In the absence of drugs or vaccines, the virus spreads unchecked. But what is this virus we have never met? Where does it come from? Why is it so infectious and how can our bodies fight it? How do we know how many of us are infected, and can we predict what the future of COVID-19 will look like?

  • What is a coronavirus? Gijs Versteeg, Immunologist
  • Where did COVID-19 come from? Manuela Baccarini, Cell Biologist
  • Why is SARS-CoV-2 so infectious? Thomas Leonard, Structural Biologist
  • How would my body fight a coronavirus infection? Thomas Decker, Immunologist
  • What is herd immunity? Pavel Kovarik, Immunologist
  • What are we doing to fight coronavirus? Tim Skern, Virologist
  • What is the future for COVID-19? Pavel Kovarik, Immunologist
  • On the origins of SARS-CoV-2: putting conspiracy theories to bed Thomas Leonard, Structural Biologist
  • Are COVID-19 numbers misleading? Manuela Baccarini, Cell Biologist
  • Mutation of SARS-CoV-2 – could it get worse? GijsVersteeg, Immunologist
  • In the quest for a cure: success stories and challenges Pavel Kovarik, Immunologist
  • A vaccine against SARS-CoV-2? Tim Skern, Virologist
  • Enhancing innate immunity – why Tb vaccines and interferons may help against COVID-19 Thomas Decker, Immunologist
  • External Sources

What is a coronavirus? Gijs Versteeg, Immunologist

Coronaviruses are readily recognizable from their spike-like projections on the surface of the virus particle. The crown-like shape of these spikes gives these viruses their name and is critical for the virus to infect its host.

 

Unlike other pathogens such as bacteria, viruses are not alive. If they are left on abiotic materials such as metal or plastic surfaces, they will not multiply. However, they can cause devastating disease when they infect humans. The reason is that in their core, viruses are packages for a piece of malicious genetic code. Upon delivery to human host tissues during infection, this code drives the production of viral factors that take over infected cells, and ensure the production and release of thousands of new infectious virus particles. These new virus particles in turn infect other cells, causing rapid virus spread and disease in the infected person.

The virus that causes the disease COVID-19 (SARS-CoV-2) packages its piece of malicious genetic code inside a lipid shell that is decorated with “Spike” structures. These spikes bind to specific receptors on lung and respiratory tract cells (called ACE-2), which fuses the virus particle with the host cell, delivers the genetic code, and starts the infection cycle. The bulky ends of the spikes give these viruses a crown-like shape (corona in Latin), from which their name is derived. The lipid shell in which the Spike proteins are anchored dissolves in soap when washing hands, rendering the virus particles non-infectious.

After entry, the released viral genetic material is decoded inside the infected cell into viral factors, thereby starting the hostile take-over of the infected cell, and production of new virus particles during the viral life cycle.

In addition to the spike, coronavirus particles are composed of structural components that both encapsulate the genetic code material (nucleocapsid) and give the virus particles their structure (membrane and envelope proteins). To replicate itself, the virus also encodes an enzyme to copy its genetic code (polymerase), and factors to inhibit the host’s immune defenses (accessory proteins). The accessory proteins are often important factors in determining the severity of disease, and may explain differences in the mortality rates between coronaviruses, such as SARS, MERS and COVID-19, that have claimed many lives in the last decade.

Where did COVID-19 come from? Manuela Baccarini, Cell Biologist

Coronaviruses infect many animal species as well as humans. COVID-19 is what’s called a ‘zoonosis’, which means that this disease jumped species into humans, probably through close contact with animals.

The causative agent of the disease COVID-19 is a coronavirus, (SARS-CoV-2). COVID-19 is a zoonosis, which means that it can be transmitted to humans from animals. Zoonoses caused by cross-species transmission represent 60% of the emerging infectious diseases worldwide, and are often life-threatening. We all remember the influenza pandemics caused by viruses that crossed the barrier from birds or swine to humans. Cross-species transmission often occurs when animals and humans are in close contact, such as large animal farms, or crowded food markets where live animals are sold. But how do these viruses make the jump to a new species? Ultimately, to infect a new host, the viral proteins involved in transmission must be able to bind to receptors present on the surface of cells in the new species. The changes usually arise from error-prone replication of the viral genome. As an example, the gene coding for the Spike protein, which binds to the receptor of SARS-CoV-2 in humans, is a mutational hotspot. Coronaviruses, like influenza viruses, can also exchange parts of their genome with other viruses during a coinfection. When such major genomic changes happen in the right region, they can generate new chimeric viruses capable of infecting a new host.

Zoonoses become really threatening when the viruses are able to efficiently spread from human to human, usually by droplet infection, as is the case for SARS-CoV-2 and related viruses – our species doesn’t “know” the virus and is therefore not protected. Identifying the species of origin and possible intermediate hosts is extremely important to be able to control future transmission events. In the case of COVID-19, full-length genome sequences of the SARS-CoV-2 virus obtained from patients (including a worker in the now infamous food market in Wuhan) are almost identical to that of coronaviruses found in bats.

However, Coronaviruses are in many animal species besides bats, and SARS-CoV-2 is not the only one that made the jump to ours. Of the 7 coronavirus isolated from humans, 4 cause common cold symptoms; the remaining 3 cause severe respiratory disease. The most similar to SARS-CoV-2 is SARS-CoV-1, responsible for the SARS (Severe Acute Respiratory Syndrome) outbreak originating in Guangdong, China in 2002, presumably originating from civet cats sold for food in a live-animal market, which were possibly infected by contact with bats. SARS spread rapidly to more than 30 countries, but luckily there have been no SARS cases since 2004. MERS-CoV was responsible for a 2012 outbreak with a clear epicenter in the Arabian Peninsula, and was traced to dromedary camels. Both viruses took a heavy toll on human health, but COVID-19 spreads with unprecedented speed and threatens to overwhelm health systems around the world. 

Why is SARS-CoV-2 so infectious? Thomas Leonard, Structural Biologist

SARS-CoV-2, the virus that causes COVID-19, binds tightly to the surface of cells that line our respiratory tract, while asymptomatic carriers spread the infection undetected. These two factors are contributing to COVID-19 spreading with unprecedented speed around the world. 

 

Like all viruses, SARS-CoV-2 requires a host in order to replicate itself. To replicate, the virus must first gain entry to the host cell. SARS-CoV-2 does this by latching on to a protein called ACE2, or angiotensin-converting enzyme 2, found on the surface of many cells in our bodies, including the delicate structures of the lungs that allow us to breathe. But why is Covid-19 different to other coronaviruses, including the one that caused the original SARS outbreak in 2002?

Scientists have now deciphered part of the answer to that question. The spike protein of SARS-CoV-2, which decorates the surface of the virus, binds to ACE2 on the surface of human cells 10 to 20 times more tightly than the original SARS coronavirus. Researchers have recently been able to obtain a snapshot of the spike protein bound to ACE2, revealing the reasons behind this difference. One can think of it like a jigsaw puzzle in which the two pieces fit perfectly together. The better the virus can bind to our cells, the more likely it is to gain entry.

The spread of the virus, however, is exacerbated by a second factor: asymptomatic carriers. These are people who exhibit no symptoms, but are carrying around the virus. Without knowing it, these people risk spreading the virus to others. For these reasons, the track-and-trace approach of widespread testing followed by strict quarantine, successfully employed in South Korea, is essential to contain the virus and avoid overwhelming healthcare services.

How would my body fight a coronavirus infection? Thomas Decker, Immunologist

Our immune system has two arms: the rapid reaction force, called ‘innate immunity’ and a slower arm, called ‘adaptive immunity’ which mounts a highly specific attack against the pathogen. Deployment of the adaptive arm of the immune system is essential to overcome the invader and to create a memory of the virus.

 

Our immune system protects us with weapons that are very rapidly deployed and others that take some time to start operating. Very simply put, the rapid response slows down the propagation of a virus, but cannot entirely stop it. The slow response is very effective and usually lets us regain health by clearing the virus from our body. The rapid and slow responses of our immune system are called innate and adaptive immunity.

Many viruses, including Corona viruses, actively reduce the impact of the rapid immune response. This allows them to multiply before the slower arm of the immune response starts being protective. In addition, some viral diseases, including severe cases of COVID-19, are associated with severe inflammation of internal organs, particularly the lung. In a worst-case scenario the resulting pneumonia impairs lung function to the point of being life-threatening.  A second threat is that a virally infected person becomes ‘superinfected’ with a second pathogen, usually a bacterium that exacerbates inflammation. We have no information as yet on how much superinfection contributes to COVID-19, but doctors have recommended people at high risk to be vaccinated against Pneumococcus, a frequent cause of pneumonia. 

Immunity as we understand it results from the slow arm of the immune system, the adaptive immunity. Figuratively speaking, adaptive immunity builds an army consisting of antibodies and cells that search and destroy the invading pathogen, and specifically generates a memory of this invader that helps it to mount a faster and more vigorous response to a secondary infection with the same pathogen. A characteristic of immunological defence and memory is the occurrence of neutralizing antibodies in the plasma of our blood. Antibodies are proteins that bind to the virus. If they are neutralizing they prevent the virus from attaching to cells it is trying to infect.

It is still early days to form a sound judgment of immunological memory as a means to prevent re-infection with the SARS-CoV-2 virus. However, neutralizing antibodies have been found in infected persons and there is reason to hope that immunological memory will indeed mitigate the risk of getting sick again with COVID-19.

What is herd immunity? Pavel Kovarik, Immunologist

Herd immunity occurs when transmission chains are disrupted by healthy people who are immune to the virus either through vaccination or having recovered from an earlier infection. Herd immunity is essential for the eradication of diseases such as smallpox, measles and polio.

Herd immunity (also called population immunity) is a mode of protection against infectious disease. It occurs when many individuals become immune by recovering from an earlier infection or through vaccination. Immune individuals do not contribute to disease transmission so that infection chains are frequently disrupted. Consequently, the infection spread is slowed or stopped in a population in which a high percentage of individuals possess immunity. For example, herd immunity generated through vaccination was a prerequisite for the eradication of smallpox in 1977. The proportion of people who need to become immune so that herd immunity can be established is different for each infection, depending on factors such as infectivity of the pathogen or the incubation period. Herd immunity is essential to protect vulnerable people, including the elderly and immune-compromised people, against an infection.

Models simulating the spread of COVID-19 disease suggest that 60-80% people need to be immune against the SARS-CoV-2 virus to establish an efficient herd immunity. Once this threshold is reached, the high-risk population, i.e. elderly or immunosuppressed people, and people with heart or lung diseases, would be to a large degree shielded from COVID-19. Broad testing for the presence of antibodies against the SARS-CoV-2 virus in the population will provide information on the current herd immunity and its progress.

What are we doing to fight coronavirus? Tim Skern, Virologist

Limiting the spread of COVID-19 is essential to prevent healthcare services from being overwhelmed. Together with its partners across Vienna, the Max Perutz Labs are repurposing existing research infrastructure to increase the national testing capacity.

 

 

Like many other countries around the world, Austria is suffering from a lack of testing capacity. In South Korea, where new infections have been successfully reduced to practically none, 1 in 136 people have been tested, a worldwide high. The ability to track and trace is key to ensuring the disruption of infection chains, quarantining infected people as soon as possible, and lowering the burden on health care services. In collaboration with 20 other research institutions across Vienna, the Max Perutz Labs are repurposing existing laboratory infrastructure, reagents and manpower to increase the national testing capacity for SARS-CoV-2.

But how does one test a person for SARS-CoV-2? Like all viruses, SARS-CoV-2 carries its own genetic code around with it. The complete genetic code of SARS-CoV-2 was determined from a patient in Wuhan, China in early January this year. Detecting the genetic instructions of the virus is key to the major test being used around the world. Using small pieces of DNA, called primers, that match specific regions of the SARS-CoV-2 code, scientists can make thousands of copies of these segments, allowing them to be detected. Since the same code does not exist in our own DNA, a positive result confirms the presence of the virus in our cells. However, testing capacity is currently limited by the availability of high-grade reagents and high-throughput pipelines to cope with demand. Our mission is to do what we can to enhance the current testing capacity by diverting existing resources to the cause.

Another way to detect the virus is to detect the immune response in infected patients. The antibodies that the body makes against the virus can be detected in a test that is called an Enzyme-Linked Immuno-Sorbent Assay, or ELISA for short. A virus-specific protein, made in a laboratory, is immobilized on a surface, allowing it to be probed with a blood sample taken from the patient. If the patient is infected or has recovered from an infection, antibodies against the viral protein will bind tightly to it. These antibodies are then detected in a second step that is coupled to a light-emitting or color-changing enzymatic reaction. Development of such a test is critical for assessing the level of immunity developing in a population. Since SARS-CoV-2 goes undetected in many asymptomatic carriers, it is difficult to estimate the number of people who are infected and the proportion that develop severe disease. The Max Perutz Labs and its partners are actively working towards the development and implementation of such a test.

What is the future for COVID-19? Pavel Kovarik, Immunologist

SARS-CoV-2 is still very new to us. Basic research is unraveling fundamental properties of the virus while clinical labs around the world are working with unprecedented speed to develop tools to stop its spread. As more and more is learned, predictions about the future of COVID-19 will become increasingly robust. 

People around the world are now asking what will be the future for the COVID-19 pandemic. Will the disease and the SARS-CoV-2 virus disappear, similar to SARS-CoV in 2004 and MERS-CoV in 2012? Or will the disease become part of our lives similar to flu? Will there be a treatment and/or vaccine? Definitive answers to these important questions are not available yet because the virus and the disease are new. However, based on current knowledge it is possible to discuss likely and less likely scenarios for the future of COVID-19.

The virus appears to be highly contagious; its infectivity is higher than that of coronaviruses in previous epidemics. This property contributes to the rapid spreading of the virus around the world. Moreover, the combination of a long incubation time (up to 2 weeks) with an extended period of virus shedding in COVID-19 patients (up to several weeks according to recent reports) and a high percentage of asymptomatic infections allows dissemination of the virus under the radar, thereby further worsening the pandemic. This fast growth in the number of infected people worldwide might help establish a herd immunity relatively soon, provided that recovered patients develop immunity to the virus. Fortunately, this appears to be the case: so far there is little evidence that patients can get re-infected with the virus. Thus, it can be assumed that most people can generate a protective immunity against the virus – this is good news for the development of vaccines against SARS-CoV-2. Vaccination would further facilitate the establishment of herd immunity and, consequently, perhaps eradication of the virus. Yet, viruses often have the unpleasant property of mutating their coat such that they cannot be recognized by the immune system, which was trained to attack the previous version of the virus. This is well known from the annual flu epidemics: every year a slightly different influenza virus evolves so that a lasting immunity against flu cannot be achieved. The available data on the mutation rate of SARS-CoV-2 provide grounds for some optimism: mutations in SARS-CoV-2 occur about two to four times slower than in the flu virus suggesting that immunity (generated during an infection or through vaccination) against SARS-CoV-2 could be more persistent than against flu.

In all likelihood, lasting strategies against COVID-19 will come from the research that is now spreading around the globe as quickly as the virus. Development of new drugs, re-purposing of known drugs, vaccination and other approaches are being pursued by companies and academic institutes worldwide, including those in Austria. Several promising results have already been achieved in the treatment of COVID-19 and the first vaccination trials have been initiated. The goals are clear: defeat the virus and learn the lessons so that we are better prepared for similar challenges in the future.

On the origins of SARS-CoV-2: putting conspiracy theories to bed Thomas Leonard, Structural Biologist

The media has widely reported claims that SARS-CoV-2 did not arise naturally but may have been deliberately created and released by scientists. The evidence, however, unequivocally supports a natural origin of the virus.

In April, concerns about a high-security virus facility in Wuhan, China, the epicenter of the COVID-19 outbreak, became the focus of media attention. Conspiracy theories rapidly circulated, ranging from an unfortunate accident to the more malicious deliberate engineering of a synthetic virus, the equivalent of an act of biological warfare. So what do we know about SARS-CoV-2 that can help us understand its origins?

Scientists have already been forensically examining the sequences of thousands of SARS-CoV-2 isolates. Fortunately, we know the genetic instructions of other coronaviruses as well as their mutation rates and biological processes that can change their genetic code. By comparing the genetic code of SARS-CoV-2 to those of other coronaviruses, scientists can date relatively accurately the likely time at which viruses diverged from a common ancestor. These in-depth analyses clearly demonstrate that the SARS-CoV-2 virus could not have occurred in a lab and is unlikely to have occurred in a pangolin. Most likely, SARS-CoV-2, like its cousin SARS-CoV from 2003, arose in a bat cave in the south-west of China some four decades ago.

SARS-CoV-2 contains a four amino acid insertion in part of its Spike protein that generates what is called a “furin cleavage site”. This means that the Spike can be cleaved by an enzyme in our cells, called furin; such cleavages have been shown to promote viral entry in related coronaviruses like the MERS virus. But where did this sequence come from? Sequence analysis of the SARS-CoV-2 genome strongly indicates that the sequence almost certainly did not arise from deliberate engineering of a bat coronavirus. Instead, the insertion likely arose from an event called a copy-choice error, which can arise when two or more related virus particles infect the same cell. In this co-infected cell, the enzyme that copies the viral genome (termed RNA polymerase) jumps from one virus’s RNA to another virus’s RNA during copying. As a consequence, RNA segments from two viruses are swapped leading to a novel combination of RNA molecules that did not previously exist. Indeed, the RNA sequence of the furin site insertion in SARS-CoV-2 is almost identical to that of the bat coronavirus HKU9 isolated in 2011, suggesting that HKU9 was one of the co-infecting viruses.

In summary: neither the part of the Spike protein that binds so effectively to our cells nor the furin cleavage site in the Spike protein arose by deliberate manipulation of a related virus. On the contrary, the above analyses show that the process was an entirely natural one that is frequently observed in coronaviruses, and has strong medical relevance in other viruses such as poliovirus and HIV.

Are COVID-19 numbers misleading? Manuela Baccarini, Cell Biologist

Have we flattened the curve? Can we resume our normal life? In a pandemic, the decision on how to proceed should be based on hard facts collected by epidemiologists.

Epidemiologists study patterns of disease in humans, including the number of infected individuals. These numbers have never been more available in real time than for the current COVID-19 pandemic. Many renowned institutions maintain websites through which we can watch the virus in action: how many cases in total, how many active cases – and the outcomes, recovered versus deaths. These numbers are the best we have and are used to make informed decisions. Unfortunately, however, they are at best a vague indication of our interaction with the virus.

The problem is that different countries use different methods to test and report COVID-19 cases. Why is this a problem? If we all test for the presence of the virus, we should all get the same results. However, diagnostic tests differ in sensitivity and in the probabilities of returning false positives and false negatives. In addition, some countries report both cases confirmed by laboratory tests and probable cases, defined as patients with symptoms who interacted with confirmed cases; suspected cases, i.e. patients that show COVID-19 symptoms but have neither been tested nor in contact with confirmed cases, are not reported. This also applies, of course to reporting COVID-19 as a cause of death. However, while deaths are certain, asymptomatic infections are invisible and therefore make up the largest contingent of unreported cases.

So how many COVID-19 cases are really out there? Nobody knows, but it is safe to assume that the actual number of cases is much higher than the numbers we read in the news. So if we really want to know how infectious the virus is and, by extension, what the true mortality rate is, there’s only one way: testing, testing, testing – and using standardized methods. The recent announcement by the Swiss pharmaceutical company Roche of a reliable ELISA test (see ‘What are we doing to fight coronavirus?’) is therefore welcome news.

Mutation of SARS-CoV-2 – could it get worse? GijsVersteeg, Immunologist

Viruses exploit error-prone replication of their genetic instructions to drive successful dissemination in their hosts. How does this work and what do we know about this process in SARS-CoV-2?

Humans have genetic material (DNA) that codes for all the factors that build up the different cells forming our bodies. Many viruses (including SARS-CoV-2) use a similar type of genetic material (RNA) to code for different, virus-specific factors needed for their life cycle. Two opposing biological principles in the replication of genetic material drive the evolutionary success of humans and viruses.

Humans are made up of many different cells, and copy their genetic material as precisely as possible when cells double during growth. The reason for this is that mistakes in just one of the many cells in a human body could be disastrous for the whole organism, as is, for example, the case when a single cell becomes cancerous.

In contrast, viruses thrive with the opposite strategy of replicating their genetic material with less fidelity, generating billions of progeny virus particles, each one slightly different from the other. Why would this be beneficial for the virus? Most of these changes are neutral or detrimental for infectivity, and will not be transmitted to other humans. However, a few of the viral genetic variants may now multiply faster, be transmitted more efficiently between individuals, or avoid recognition by antibodies generated by our immune systems. These viral variants will spread throughout the human population more efficiently.

The full genetic code of SARS-CoV-2 isolated from several thousand different COVID-19 patients has been determined; the viral genetic code is indeed showing signs of selection pressure. One of the genetic regions with alterations is the part encoding the viral entry protein (Spike), which may increase the strength of interaction of the virus with receptors on the surface of cells, or prevent efficient binding of otherwise neutralizing antibodies to it. Other alterations could potentially interfere with some of the current diagnostics. However, the influence of these mutations on viral fitness and virus detection remain unclear and will require further investigation.

In the quest for a cure: success stories and challenges Pavel Kovarik, Immunologist

Without a vaccine, what tools do we have to treat COVID-19? Can we actually treat the disease effectively or are we simply deploying lifeboats in the most urgent cases?

The reason for the global COVID-19 crisis is the lack of effective treatments. Current medication focuses on mitigation of the disease symptoms (symptomatic treatment) rather than on targeting the cause of the disease, i.e. the SARS-CoV-2 virus. Symptomatic treatment is a common strategy against many diseases, and it can also help against COVID-19. For example, severely sick COVID-19 patients receive oxygen to compensate for their lung insufficiency. Fever-reducing agents are another class of symptomatic medications for COVID-19. Promising symptomatic treatments are medications aimed at reducing the so called “cytokine storm” which is an immune reaction that has spiraled out of control and has a high risk of life-threatening lung damage.

Nevertheless, interventions directly targeting SARS-CoV-2 would tremendously enhance our ability to treat COVID-19. One such strategy employs the administration of blood serum obtained from people who recovered from COVID-19. The anti-SARS-CoV-2 antibodies present in these sera help the patients in multiple ways (for example, by preventing the virus from entering the cells). However, this successful therapy cannot be used on a large scale since the number of healthy serum donors is limited.

In the absence of a vaccine, drugs targeting the virus represent the best means for a broad and affordable treatment. One such drug is remdesivir, which interferes with the viral replication machinery. Originally developed against the Ebola virus, the drug appears to be also partially effective against SARS-CoV-2. However, drug repurposing has a high chance of failure. Chloroquine (a common anti-malarial drug) can block SARS-CoV-2 but has significant adverse side effects in COVID-19 patients. Drugs against the flu virus are, in general, ineffective against SARS-CoV-2. Thus, the challenge is to develop new drugs that are safe and precisely target SARS-CoV-2. Scientists are therefore searching for the Achilles’ heel in the SARS-CoV-2 life cycle that could be effectively targeted.

A vaccine against SARS-CoV-2? Tim Skern, Virologist

A vaccine, when available, will certainly be the most effective measure to control SARS-CoV-2. Before we look at the approaches being taken against SARS-CoV-2, let us look at how a vaccine works.

Vaccines are our most powerful health measure to prevent viral infections and thus protect ourselves against the diseases they cause. Simply put, a vaccine simulates a real infection in the body without the disease breaking out. The body then mounts a defense against these invaders that is memorised and can be reactivated should a genuine infection take place. Vaccines that protect against viral diseases come in three basic types. The most effective ones are called live vaccines. They contain a weakened virus (termed attenuated) that can still multiply in the body but without causing disease. Examples of this type are the measles and mumps vaccines. Inactivated viral vaccines (also referred to as killed vaccines) contain virus particles that have been chemically inactivated with for example formaldehyde. In contrast to live vaccines, they do not multiply but the viral particles are still recognised as foreign bodies so that the immune system can build a response. Inactivated vaccines, such as the one against tick-borne encephalitis virus (FSME), usually have to be injected more that once to ensure protection. The third types of viral vaccine, such as the flu vaccine, contain just certain parts of the virus that are required to generate protection.

Vaccines of all three types are being developed against SARS-CoV-2 by around 70 different institutes and companies. For instance, an inactivated vaccine is being tested in monkeys by a company in China. It will be many years before an attenuated vaccine against SARS-CoV-2 can be generated. Instead, researchers have turned to other viruses that can present the SARS-CoV-2 spike protein without causing disease. One promising approach that uses a monkey virus has already been shown to generate antibodies in humans against the related MERS virus. A similar vaccine against SARS-CoV-2 is now in clinical trials in humans. Even if current trials prove safe and show that antibodies are generated, it will still take many months to produce enough vaccine for the whole world. Until, then, the best methods to prevent infection by SARS-CoV-2 will remain social distancing and hand-washing with soap.

Enhancing innate immunity – why Tb vaccines and interferons may help against COVID-19 Thomas Decker, Immunologist

Vaccines harness the power of our adaptive immune system, but our innate immune system can also help. Here, we take a look at ways in which our innate immune system can work against SARS-CoV-2.

Immunological memory and immunity against pathogens are usually attributed to the adaptive immune system (see: How would my body fight a coronavirus infection?). However, this is not the whole truth. Our innate immune system also remembers a previous encounter with microorganisms or viruses. This innate memory, also called trained immunity, is fundamentally different from the memory lymphocytes and antibodies produced by the adaptive immune system.

The biggest difference is that our innate immune system acts broadly and not only against the same pathogen that caused the immune response in the first place. For example, animals treated with bacterial vaccines have been found to display enhanced immunity against a subsequent viral infection. Trained immunity by the innate immune system triggered researchers from the German Max Planck Society to develop the idea of using an improved and clinically approved vaccine against Tuberculosis (Tb) to protect against SARS-CoV-2. The scientists think the bacteria in the vaccine may help to harness the innate immune system against SARS-CoV-2. Since the vaccine is already approved for use, it can be tested immediately in clinical trials.

Another potentially helpful substance is interferon (IFN). IFN is released by our innate immune system as a response to viral infection. In fact, the name stems from its ability to ‘interfere’ with viral replication inside cells. Interferons are approved clinical treatments against cancer and viral infections. Thus, they could be tested in a small cohort of COVID-19 patients and were found to increase clearance of the virus in the upper respiratory tract. However, another study cautions against the use of IFN. The authors report that IFN increases expression of the receptor for SARS-CoV-2 entry (ACE2) on airway epithelial cells. Thus, beneficial and potentially harmful effects of IFN treatment must be carefully evaluated in future clinical trials.